$ehc 2017 Q4 10-K

Concept	2017 Q4	2017 Q3	2017 Q2
Revenue	$1.020B	$995.6M	$966.4M
YoY Change	7.35%	7.42%	4.96%
Cost Of Revenue	$38.70M	$36.50M	$37.10M
YoY Change	8.1%	4.89%	7.85%
Gross Profit	$970.1M	$942.6M	$930.5M
YoY Change	7.84%	7.46%	6.84%
Gross Profit Margin	95.14%	94.68%	96.29%
Selling, General & Admin	$616.4M	$600.4M	$598.5M
YoY Change	7.97%	10.1%	10.81%
% of Gross Profit	63.54%	63.7%	64.32%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$46.60M	$46.20M	$45.80M
YoY Change	6.39%	6.21%	6.76%
% of Gross Profit	4.8%	4.9%	4.92%
Operating Expenses	$801.3M	$780.3M	$774.8M
YoY Change	8.31%	9.12%	9.98%
Operating Profit	$144.7M	$145.2M	$141.3M
YoY Change	-0.55%	-2.02%	-5.93%
Interest Expense	-$34.10M	$36.80M	$40.40M
YoY Change	-12.79%	-13.41%	-6.91%
% of Operating Profit	-23.57%	25.34%	28.59%
Other Income/Expense, Net	$1.200M	$1.000M	$900.0K
YoY Change	50.0%	25.0%	28.57%
Pretax Income	$135.9M	$128.3M	$107.8M
YoY Change	11.85%	6.65%	-12.85%
Income Tax	$34.40M	$43.10M	$28.60M
% Of Pretax Income	25.31%	33.59%	26.53%
Net Earnings	$75.40M	$65.90M	$63.00M
YoY Change	15.47%	6.81%	0.64%
Net Earnings / Revenue	7.39%	6.62%	6.52%
Basic Earnings Per Share	$0.77	$0.67	$0.70
Diluted Earnings Per Share	$0.76	$0.67	$0.70
COMMON SHARES
Basic Shares Outstanding	98.31M shares	97.80M shares	90.30M shares
Diluted Shares Outstanding		99.00M shares	98.90M shares

Concept	2017 Q4	2017 Q3	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$54.40M	$67.60M	$71.10M
YoY Change	34.32%	-11.52%	1.14%
Cash & Equivalents	$54.40M	$67.60M	$71.10M
Short-Term Investments
Other Short-Term Assets	$113.3M	$178.2M	$195.9M
YoY Change	-33.43%	4.58%	16.19%
Inventory
Prepaid Expenses
Receivables	$459.5M	$441.6M	$426.5M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$702.2M	$687.4M	$693.5M
YoY Change	7.29%	3.21%	5.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.517B	$1.482B	$1.452B
YoY Change	9.0%	9.55%	8.62%
Goodwill	$1.973B	$1.972B	$1.950B
YoY Change	2.36%	2.93%	2.63%
Intangibles	$403.1M	$405.1M	$404.8M
YoY Change	-1.99%	-1.22%	-2.27%
Long-Term Investments	$11.70M
YoY Change	-7.87%
Other Assets	$235.1M	$245.3M	$237.9M
YoY Change	6.24%	14.68%	15.04%
Total Long-Term Assets	$4.162B	$4.196B	$4.147B
YoY Change	3.35%	5.82%	4.36%
TOTAL ASSETS
Total Short-Term Assets	$702.2M	$687.4M	$693.5M
Total Long-Term Assets	$4.162B	$4.196B	$4.147B
Total Assets	$4.865B	$4.883B	$4.840B
YoY Change	3.9%	5.44%	4.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$78.40M	$81.80M	$77.50M
YoY Change	14.79%	21.19%	15.5%
Accrued Expenses	$196.8M	$398.3M	$377.5M
YoY Change	13.69%	7.16%	6.19%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$32.30M	$31.10M	$38.30M
YoY Change	-12.94%	-15.49%	4.93%
Total Short-Term Liabilities	$517.5M	$511.2M	$493.3M
YoY Change	8.81%	7.39%	7.45%
LONG-TERM LIABILITIES
Long-Term Debt	$2.545B	$2.591B	$2.625B
YoY Change	-14.56%	-12.87%	-13.93%
Other Long-Term Liabilities	$75.20M	$186.4M	$182.6M
YoY Change	51.61%	17.9%	18.49%
Total Long-Term Liabilities	$75.20M	$186.4M	$182.6M
YoY Change	51.61%	17.9%	18.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$517.5M	$511.2M	$493.3M
Total Long-Term Liabilities	$75.20M	$186.4M	$182.6M
Total Liabilities	$3.248B	$3.289B	$3.301B
YoY Change	-10.14%	-8.85%	-9.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.176B
YoY Change	-18.79%
Common Stock	$1.100M
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$418.5M
YoY Change	-31.92%
Treasury Stock Shares	13.39M shares
Shareholders Equity	$1.153B	$1.136B	$1.104B
YoY Change
Total Liabilities & Shareholders Equity	$4.865B	$4.883B	$4.840B
YoY Change	3.9%	5.44%	4.48%

Concept	2017 Q4	2017 Q3	2017 Q2
OPERATING ACTIVITIES
Net Income	$75.40M	$65.90M	$63.00M
YoY Change	15.47%	6.81%	0.64%
Depreciation, Depletion And Amortization	$46.60M	$46.20M	$45.80M
YoY Change	6.39%	6.21%	6.76%
Cash From Operating Activities	$151.4M	$173.8M	$151.2M
YoY Change	4.49%	3.64%	-0.66%
INVESTING ACTIVITIES
Capital Expenditures	-$74.70M	-$60.70M	-$64.80M
YoY Change	4.48%	35.49%	36.42%
Acquisitions
YoY Change
Other Investing Activities	-$600.0K	-$16.90M	-$13.00M
YoY Change	-96.51%	181.67%	-29.73%
Cash From Investing Activities	-$75.30M	-$77.60M	-$77.80M
YoY Change	-15.11%	52.76%	17.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-89.30M	-99.70M	-63.50M
YoY Change	-3.04%	-10.02%	-28.73%
NET CHANGE
Cash From Operating Activities	151.4M	173.8M	151.2M
Cash From Investing Activities	-75.30M	-77.60M	-77.80M
Cash From Financing Activities	-89.30M	-99.70M	-63.50M
Net Change In Cash	-13.20M	-3.500M	9.900M
YoY Change	-63.23%	-157.38%	-441.38%
FREE CASH FLOW
Cash From Operating Activities	$151.4M	$173.8M	$151.2M
Capital Expenditures	-$74.70M	-$60.70M	-$64.80M
Free Cash Flow	$226.1M	$234.5M	$216.0M
YoY Change	4.48%	10.35%	8.16%

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q2	dei	Entity Public Float EntityPublicFloat	6600000000	USD
CY2018	dei	Entity Registrant Name EntityRegistrantName	ENCOMPASS HEALTH CORP
CY2018	dei	Entity Shell Company EntityShellCompany	false
CY2018	dei	Entity Small Business EntitySmallBusiness	false
CY2018	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2018	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2018	dei	Amendment Flag AmendmentFlag	false
CY2018	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2018	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018	dei	Document Period End Date DocumentPeriodEndDate	2018-12-31
CY2018	dei	Document Type DocumentType	10-K
CY2018	dei	Entity Central Index Key EntityCentralIndexKey	0000785161
CY2019Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	98743918	shares
CY2018	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2018	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2018	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q4	ehc	Bonus Depreciation Deductions BonusDepreciationDeductions	8800000	USD
CY2017Q1	ehc	Class Of Warrant Or Right Numberof Securities Expired ClassOfWarrantOrRightNumberofSecuritiesExpired	1100000	shares
CY2018Q4	ehc	Consolidatedcoverageratiominimum Consolidatedcoverageratiominimum	2
CY2018Q4	ehc	Debt Instrument Covenant Leverage Ratio Maximum DebtInstrumentCovenantLeverageRatioMaximum	2
CY2016	ehc	Effective Income Tax Rate Reconciliation Sharebasedwindfalltaxbenefits Percent EffectiveIncomeTaxRateReconciliationSharebasedwindfalltaxbenefitsPercent	0.000
CY2017	ehc	Effective Income Tax Rate Reconciliation Sharebasedwindfalltaxbenefits Percent EffectiveIncomeTaxRateReconciliationSharebasedwindfalltaxbenefitsPercent	-0.018
CY2018	ehc	Effective Income Tax Rate Reconciliation Sharebasedwindfalltaxbenefits Percent EffectiveIncomeTaxRateReconciliationSharebasedwindfalltaxbenefitsPercent	-0.004
CY2016	ehc	Equity Method Investment Summarized Financial Information Operating Expenses EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses	-24300000	USD
CY2017	ehc	Equity Method Investment Summarized Financial Information Operating Expenses EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses	-24100000	USD
CY2018	ehc	Equity Method Investment Summarized Financial Information Operating Expenses EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses	-25600000	USD
CY2017Q4	ehc	Equity Method Investments Accumulated Dividendsor Distributionsfrom Equity Method Investments EquityMethodInvestmentsAccumulatedDividendsorDistributionsfromEquityMethodInvestments	-94500000	USD
CY2018Q4	ehc	Equity Method Investments Accumulated Dividendsor Distributionsfrom Equity Method Investments EquityMethodInvestmentsAccumulatedDividendsorDistributionsfromEquityMethodInvestments	-102700000	USD
CY2017Q4	ehc	Equity Method Investments Accumulated Income Lossfrom Equity Method Investments EquityMethodInvestmentsAccumulatedIncomeLossfromEquityMethodInvestments	105300000	USD
CY2018Q4	ehc	Equity Method Investments Accumulated Income Lossfrom Equity Method Investments EquityMethodInvestmentsAccumulatedIncomeLossfromEquityMethodInvestments	114000000	USD
CY2016	ehc	Healthcare Plan Expense HealthcarePlanExpense	119000000	USD
CY2017	ehc	Healthcare Plan Expense HealthcarePlanExpense	120800000	USD
CY2018	ehc	Healthcare Plan Expense HealthcarePlanExpense	134900000	USD
CY2016	ehc	Income Loss From Continuing Operations Attributable To Common Shareholders Basic IncomeLossFromContinuingOperationsAttributableToCommonShareholdersBasic	246800000	USD
CY2017	ehc	Income Loss From Continuing Operations Attributable To Common Shareholders Basic IncomeLossFromContinuingOperationsAttributableToCommonShareholdersBasic	270600000	USD
CY2018	ehc	Income Loss From Continuing Operations Attributable To Common Shareholders Basic IncomeLossFromContinuingOperationsAttributableToCommonShareholdersBasic	290300000	USD
CY2016	ehc	Income Loss From Continuing Operations Attributable To Common Shareholders Diluted IncomeLossFromContinuingOperationsAttributableToCommonShareholdersDiluted	257300000	USD
CY2017	ehc	Income Loss From Continuing Operations Attributable To Common Shareholders Diluted IncomeLossFromContinuingOperationsAttributableToCommonShareholdersDiluted	282300000	USD
CY2018	ehc	Income Loss From Continuing Operations Attributable To Common Shareholders Diluted IncomeLossFromContinuingOperationsAttributableToCommonShareholdersDiluted	291200000	USD
CY2017Q4	ehc	Intercompany Receivablesand Investmentsin Consolidated Affiliates IntercompanyReceivablesandInvestmentsinConsolidatedAffiliates	0	USD
CY2018Q4	ehc	Intercompany Receivablesand Investmentsin Consolidated Affiliates IntercompanyReceivablesandInvestmentsinConsolidatedAffiliates	0	USD
CY2017Q4	ehc	Investments Cashand Restricted Cash InvestmentsCashandRestrictedCash	178800000	USD
CY2018Q4	ehc	Investments Cashand Restricted Cash InvestmentsCashandRestrictedCash	195500000	USD
CY2016	ehc	Liabilityfor Unpaid Claimsand Claims Adjustment Expense Discontinued Operations LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDiscontinuedOperations	-400000	USD
CY2017	ehc	Liabilityfor Unpaid Claimsand Claims Adjustment Expense Discontinued Operations LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDiscontinuedOperations	-500000	USD
CY2018	ehc	Liabilityfor Unpaid Claimsand Claims Adjustment Expense Discontinued Operations LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDiscontinuedOperations	-200000	USD
CY2018Q4	ehc	Loss Contingency Minimum Amountto Consider Accruingan Estimateof Related Legal Fees LossContingencyMinimumAmounttoConsiderAccruinganEstimateofRelatedLegalFees	5000000	USD
CY2016	ehc	Management Fees ManagementFees	0	USD
CY2017	ehc	Management Fees ManagementFees	0	USD
CY2018	ehc	Management Fees ManagementFees	0	USD
CY2018Q4	ehc	Maximum Self Insured Risk MaximumSelfInsuredRisk	30000000	USD
CY2018Q4	ehc	Medicare Denials Percentage Collected After Appeal Including Administrative Law Judge Hearings MedicareDenialsPercentageCollectedAfterAppealIncludingAdministrativeLawJudgeHearings	0.70
CY2016	ehc	Net Income Loss Availableto Common Stockholders NetIncomeLossAvailabletoCommonStockholders	246800000	USD
CY2017	ehc	Net Income Loss Availableto Common Stockholders NetIncomeLossAvailabletoCommonStockholders	270200000	USD
CY2018	ehc	Net Income Loss Availableto Common Stockholders NetIncomeLossAvailabletoCommonStockholders	291400000	USD
CY2018Q1	ehc	Noncontrolling Interests Decreasefrom Redemptionsor Purchaseof Interests Percent NoncontrollingInterestsDecreasefromRedemptionsorPurchaseofInterestsPercent	0.056
CY2018Q4	ehc	Number Of General Or Limited Partnerships Limited Liability Companies Or Joint Ventures NumberOfGeneralOrLimitedPartnershipsLimitedLiabilityCompaniesOrJointVentures	4	subsidiary
CY2017Q4	ehc	Number Of Individual Claims Covered By Self Insured Risk Reserves NumberOfIndividualClaimsCoveredBySelfInsuredRiskReserves	1000	claim
CY2018Q4	ehc	Number Of Individual Claims Covered By Self Insured Risk Reserves NumberOfIndividualClaimsCoveredBySelfInsuredRiskReserves	1000	claim
CY2018Q4	ehc	Number Of Partially Owned Subsidiaries Nonconsolidated NumberOfPartiallyOwnedSubsidiariesNonconsolidated	5	subsidiary
CY2018Q4	ehc	Number Of Sale Leaseback Transactions NumberOfSaleLeasebackTransactions	3	transaction
CY2016	ehc	Operating Leases Rent Expense Other OperatingLeasesRentExpenseOther	4000000	USD
CY2017	ehc	Operating Leases Rent Expense Other OperatingLeasesRentExpenseOther	8900000	USD
CY2018	ehc	Operating Leases Rent Expense Other OperatingLeasesRentExpenseOther	9100000	USD
CY2018	ehc	Ownership Percentage Of Subsidiary Guarantors OwnershipPercentageOfSubsidiaryGuarantors	1
CY2018Q4	ehc	Percentageofassetspledgedtolendersundercreditagreement Percentageofassetspledgedtolendersundercreditagreement	0.70
CY2016	ehc	Proceedsfrom Paymentsfor Advanceto Affiliate ProceedsfromPaymentsforAdvancetoAffiliate	0	USD
CY2017	ehc	Proceedsfrom Paymentsfor Advanceto Affiliate ProceedsfromPaymentsforAdvancetoAffiliate	0	USD
CY2018	ehc	Proceedsfrom Paymentsfor Advanceto Affiliate ProceedsfromPaymentsforAdvancetoAffiliate	0	USD
CY2017Q4	ehc	Property Plant And Equipment Fully Depreciated Assets PropertyPlantAndEquipmentFullyDepreciatedAssets	318600000	USD
CY2018Q4	ehc	Property Plant And Equipment Fully Depreciated Assets PropertyPlantAndEquipmentFullyDepreciatedAssets	311700000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2588700000	USD
CY2016	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	11600000	USD
CY2017	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	19800000	USD
CY2018	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	8300000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	17300000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	129100000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	155500000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1300000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2747400000	USD
CY2017Q4	ehc	Restricted Marketable Securities Current RestrictedMarketableSecuritiesCurrent	17800000	USD
CY2017Q4	ehc	Restricted Marketable Securities Noncurrent RestrictedMarketableSecuritiesNoncurrent	44200000	USD
CY2018Q4	ehc	Restricted Marketable Securities Noncurrent RestrictedMarketableSecuritiesNoncurrent	62000000	USD
CY2016	ehc	Senior Management Bonus Program Total Costs SeniorManagementBonusProgramTotalCosts	11200000	USD
CY2017	ehc	Senior Management Bonus Program Total Costs SeniorManagementBonusProgramTotalCosts	14700000	USD
CY2018	ehc	Senior Management Bonus Program Total Costs SeniorManagementBonusProgramTotalCosts	20400000	USD
CY2009Q3	ehc	Stock Issued During Period Value Warrants Exercised Shares StockIssuedDuringPeriodValueWarrantsExercisedShares	5000000	shares
CY2017Q1	ehc	Stock Issued During Period Value Warrants Exercised Shares StockIssuedDuringPeriodValueWarrantsExercisedShares	700000	shares
CY2017	ehc	Stock Issued During Period Value Warrants Exercised Value StockIssuedDuringPeriodValueWarrantsExercisedValue	26600000	USD
CY2017Q4	ehc	Tax Expenseor Benefit Resultingfromthe Tax Cutsand Jobs Act TaxExpenseorBenefitResultingfromtheTaxCutsandJobsAct	13600000	USD
CY2016	ehc	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2017	ehc	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2017	ehc	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2016	ehc	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2018	ehc	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedIncreasesResultingFromPriorPeriodTaxPositions	100000	USD
CY2016	ehc	Unrecognized Tax Benefits Income Tax Penaltiesand Interest Accrued Decreases Resultingfrom Current Period Tax Positions UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDecreasesResultingfromCurrentPeriodTaxPositions	0	USD
CY2016	ehc	Unrecognized Tax Benefits Income Tax Penaltiesand Interest Accrued Increases Resultingfrom Current Period Tax Positions UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedIncreasesResultingfromCurrentPeriodTaxPositions	0	USD
CY2018	ehc	Unrecognized Tax Benefits Income Tax Penaltiesand Interest Accrued Reductionsto Unrecognized Tax Benefitsasa Resultofa Lapseofthe Applicable Statuteof Limitations UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedReductionstoUnrecognizedTaxBenefitsasaResultofaLapseoftheApplicableStatuteofLimitations	0	USD
CY2017Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	12600000	USD
CY2018Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	7800000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	78400000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	90000000	USD
CY2017Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	601200000	USD
CY2018Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	623200000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	459500000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	459900000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	21400000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	21300000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	28900000	USD
CY2016	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	322100000	USD
CY2017	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	307700000	USD
CY2018	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	388100000	USD
CY2016	us-gaap	Advertising Expense AdvertisingExpense	7500000	USD
CY2017	us-gaap	Advertising Expense AdvertisingExpense	6300000	USD
CY2018	us-gaap	Advertising Expense AdvertisingExpense	6700000	USD
CY2016	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	13800000	USD
CY2017	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8700000	USD
CY2018	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4000000	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	48500000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49300000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51400000	USD
CY2016	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	21800000	USD
CY2017	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	22700000	USD
CY2018	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	24100000	USD
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	200000	shares
CY2017Q4	us-gaap	Assets Assets	4864500000	USD
CY2018Q4	us-gaap	Assets Assets	5175000000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	702200000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	662100000	USD
CY2017Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	300000	USD
CY2017Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2300000	USD
CY2017Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	64000000	USD
CY2016	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0	USD
CY2017	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0	USD
CY2018	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	600000	USD
CY2017Q4	us-gaap	Available For Sale Securities Restricted AvailableForSaleSecuritiesRestricted	62000000	USD
CY2018Q4	us-gaap	Available For Sale Securities Restricted AvailableForSaleSecuritiesRestricted	62000000	USD
CY2017Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	271500000	USD
CY2018Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	263800000	USD
CY2017Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	342900000	USD
CY2018Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	351000000	USD
CY2017Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	238300000	USD
CY2018Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	224100000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	455200000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	36200000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	28000000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	28700000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	30300000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	32300000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	299700000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	191400000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	263800000	USD
CY2017Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	104600000	USD
CY2018Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	126900000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	61600000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	40500000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54400000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69200000	USD
CY2015Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	107500000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	101400000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	116800000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	133500000	USD
CY2016	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-6100000	USD
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	15400000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	16700000	USD
CY2016	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6100000	USD
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	15400000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	16700000	USD
CY2016	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	100000	USD
CY2017	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	USD
CY2018	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	USD
CY2016	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-700000	USD
CY2017	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-600000	USD
CY2018	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	800000	USD
CY2009Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	41.40
CY2017Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	41.40
CY2017Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	41.40
CY2009Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	8200000	shares
CY2017Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	8200000	shares
CY2017Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.94
CY2017	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.98
CY2018	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.04
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	111690547	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	112492690	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	1100000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	1100000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	247600000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	271000000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	292300000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	70500000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	79100000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	83100000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	318100000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	350100000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	375400000	USD
CY2018Q4	us-gaap	Contractual Obligation ContractualObligation	871200000	USD
CY2018Q4	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	447900000	USD
CY2018Q4	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	63300000	USD
CY2018Q4	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	69700000	USD
CY2018Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	107600000	USD
CY2018Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	98100000	USD
CY2018Q4	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	84600000	USD
CY2017	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2017Q4	us-gaap	Cost Method Investments CostMethodInvestments	200000	USD
CY2018Q4	us-gaap	Cost Method Investments CostMethodInvestments	0	USD
CY2016	us-gaap	Costs And Expenses CostsAndExpenses	2993800000	USD
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	3264500000	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	3647700000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	16100000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	72200000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	103800000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	31000000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	85000000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	128000000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	14900000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	12800000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	24200000	USD
CY2017Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	2577700000	USD
CY2018Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	2514400000	USD
CY2016	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2017	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	319400000	USD
CY2018	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2018Q4	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	500000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	130500000	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	58400000	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-13700000	USD
CY2017Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	34400000	USD
CY2018Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	42900000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	132900000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	60800000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9100000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	120500000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	103900000	USD
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	11200000	USD
CY2018Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	12100000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	2400000	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	2400000	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	4600000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	190700000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	180500000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	34400000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	42900000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	154900000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	146800000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	77300000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	66000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	500000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	600000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	36300000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	30800000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	2800000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	4700000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	19500000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	33000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	14000000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	6100000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	20400000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	22500000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance	19900000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance	16800000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35800000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	33700000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	80000000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	88500000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	11400000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	15200000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	200000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	200000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	28900000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	0	USD
CY2016	us-gaap	Depreciation Depreciation	102300000	USD
CY2017	us-gaap	Depreciation Depreciation	111800000	USD
CY2018	us-gaap	Depreciation Depreciation	124200000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	172600000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	183800000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	199700000	USD
CY2016	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	84900000	USD
CY2017	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	95200000	USD
CY2018	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	103700000	USD
CY2017Q4	us-gaap	Due To Affiliate Noncurrent DueToAffiliateNoncurrent	0	USD
CY2018Q4	us-gaap	Due To Affiliate Noncurrent DueToAffiliateNoncurrent	0	USD
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.77
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.75
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.70
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.67
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.77
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.88
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.85
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.93
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.90
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.98
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.59
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.70
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.70
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.67
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.76
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.84
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.84
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.92
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.89
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.93
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.340
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.294
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.241
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.001
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.004
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.004
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.028
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.044
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.046
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.032
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.005
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.003
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.038
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.035
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.045
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0.027
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	172100000	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	188400000	USD
CY2018Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1600000	USD
CY2017Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	900000	USD
CY2018Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	900000	USD
CY2016	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	8500000	USD
CY2017	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	8600000	USD
CY2018	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	8300000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	28400000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	27700000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	10100000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	9900000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	288200000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	56900000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	27000000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	29600000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	2700000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	1400000	USD
CY2016	us-gaap	Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems	20500000	USD
CY2017	us-gaap	Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems	17000000	USD
CY2018	us-gaap	Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems	17100000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	28400000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	27700000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Minority Interest EquityMethodInvestmentSummarizedFinancialInformationMinorityInterest	13800000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Minority Interest EquityMethodInvestmentSummarizedFinancialInformationMinorityInterest	14000000	USD
CY2016	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	20500000	USD
CY2017	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	17000000	USD
CY2018	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	17100000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	18300000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	17800000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Liabilities EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities	200000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Liabilities EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities	100000	USD
CY2016	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	44800000	USD
CY2017	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	40900000	USD
CY2018	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	42600000	USD
CY2017Q4	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	11700000	USD
CY2018Q4	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	12200000	USD
CY2017Q4	us-gaap	Equity Method Investments EquityMethodInvestments	11700000	USD
CY2018Q4	us-gaap	Equity Method Investments EquityMethodInvestments	12200000	USD
CY2018	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	1700000	USD
CY2016	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	0	USD
CY2017	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	6200000	USD
CY2018	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	0	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	305200000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	35700000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	43300000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	708300000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	731600000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	403100000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	443400000	USD
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7400000	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-10700000	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	133400000	USD
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	171700000	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	220200000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	1890100000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	1927200000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	1972600000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	2100800000	USD
CY2016	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	51400000	USD
CY2017	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	45400000	USD
CY2018	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	128200000	USD
CY2018Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	USD
CY2016	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2017	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2018	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2016	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	14300000	USD
CY2016	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	247600000	USD
CY2017	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	271500000	USD
CY2018	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	291200000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	70500000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	79100000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	83100000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	482000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	496400000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	493200000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	318100000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	84700000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	79200000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	85200000	USD
CY2017Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	101500000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	350600000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	105700000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	113000000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	109400000	USD
CY2018Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	46200000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	374300000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.77
CY2017Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.75
CY2017Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.70
CY2017Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.67
CY2017Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.77
CY2017	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.88
CY2018Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.86
CY2018Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.93
CY2018Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.90
CY2018Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.27
CY2018	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.97
CY2016	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.59
CY2017Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.70
CY2018Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	119600000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	27400000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.70
CY2017Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.67
CY2017Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.76
CY2017	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.84
CY2018Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.85
CY2018Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.92
CY2018Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.89
CY2018Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.26
CY2018	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.92
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	USD
CY2017Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-300000	USD
CY2017Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	200000	USD
CY2017Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-100000	USD
CY2017Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-200000	USD
CY2017	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-400000	USD
CY2018Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-500000	USD
CY2018Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	200000	USD
CY2018Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-100000	USD
CY2018Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1500000	USD
CY2018	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1100000	USD
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2017	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-400000	USD
CY2018	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	1100000	USD
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2017Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2017Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2017Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2017Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2017	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2018Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2018Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2018Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2018Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.02
CY2018	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.01
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2017Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2017Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2017Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2017Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2017	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2018Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2018Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2018Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2018Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.02
CY2018	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.01
CY2016	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	9800000	USD
CY2017	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	8000000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	8700000	USD
CY2016	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	0	USD
CY2017	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	0	USD
CY2018	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	0	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	163900000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	39700000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28600000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	43100000	USD
CY2017Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34400000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	145800000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30000000	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29300000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30200000	USD
CY2018Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29400000	USD

CY2018Q2

dei

Entity Public Float

EntityPublicFloat

6600000000

USD

CY2018

dei

Entity Registrant Name

EntityRegistrantName

ENCOMPASS HEALTH CORP

CY2018

dei

Entity Shell Company

EntityShellCompany

false

CY2018

dei

Entity Small Business

EntitySmallBusiness

false

CY2018

dei

Entity Voluntary Filers

EntityVoluntaryFilers

No

CY2018

dei

Entity Well Known Seasoned Issuer

EntityWellKnownSeasonedIssuer

Yes

CY2018

dei

Amendment Flag

AmendmentFlag

false

CY2018

dei

Current Fiscal Year End Date

CurrentFiscalYearEndDate

--12-31

CY2018

dei

Document Fiscal Period Focus

DocumentFiscalPeriodFocus

FY

CY2018

dei

Document Fiscal Year Focus

DocumentFiscalYearFocus

2018

CY2018

dei

Document Period End Date

DocumentPeriodEndDate

2018-12-31

CY2018

dei

Document Type

DocumentType

10-K

CY2018

dei

Entity Central Index Key

EntityCentralIndexKey

0000785161

CY2019Q1

dei

Entity Common Stock Shares Outstanding

EntityCommonStockSharesOutstanding

98743918

shares

CY2018

dei

Entity Current Reporting Status

EntityCurrentReportingStatus

Yes

CY2018

dei

Entity Emerging Growth Company

EntityEmergingGrowthCompany

false

CY2018

dei

Entity Filer Category

EntityFilerCategory

Large Accelerated Filer

CY2017Q4

ehc

Bonus Depreciation Deductions

BonusDepreciationDeductions

8800000

USD

CY2017Q1

ehc

Class Of Warrant Or Right Numberof Securities Expired

ClassOfWarrantOrRightNumberofSecuritiesExpired

1100000

shares

CY2018Q4

ehc

Consolidatedcoverageratiominimum

2

CY2018Q4

ehc

Debt Instrument Covenant Leverage Ratio Maximum

DebtInstrumentCovenantLeverageRatioMaximum

2

CY2016

ehc

Effective Income Tax Rate Reconciliation Sharebasedwindfalltaxbenefits Percent

EffectiveIncomeTaxRateReconciliationSharebasedwindfalltaxbenefitsPercent

0.000

CY2017

ehc

Effective Income Tax Rate Reconciliation Sharebasedwindfalltaxbenefits Percent

EffectiveIncomeTaxRateReconciliationSharebasedwindfalltaxbenefitsPercent

-0.018

CY2018

ehc

Effective Income Tax Rate Reconciliation Sharebasedwindfalltaxbenefits Percent

EffectiveIncomeTaxRateReconciliationSharebasedwindfalltaxbenefitsPercent

-0.004

CY2016

ehc

Equity Method Investment Summarized Financial Information Operating Expenses

EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses

-24300000

USD

CY2017

ehc

Equity Method Investment Summarized Financial Information Operating Expenses

EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses

-24100000

USD

CY2018

ehc

Equity Method Investment Summarized Financial Information Operating Expenses

EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses

-25600000

USD

CY2017Q4

ehc

Equity Method Investments Accumulated Dividendsor Distributionsfrom Equity Method Investments

EquityMethodInvestmentsAccumulatedDividendsorDistributionsfromEquityMethodInvestments

-94500000

USD

CY2018Q4

ehc

Equity Method Investments Accumulated Dividendsor Distributionsfrom Equity Method Investments

EquityMethodInvestmentsAccumulatedDividendsorDistributionsfromEquityMethodInvestments

-102700000

USD

CY2017Q4

ehc

Equity Method Investments Accumulated Income Lossfrom Equity Method Investments

EquityMethodInvestmentsAccumulatedIncomeLossfromEquityMethodInvestments

105300000

USD

CY2018Q4

ehc

Equity Method Investments Accumulated Income Lossfrom Equity Method Investments

EquityMethodInvestmentsAccumulatedIncomeLossfromEquityMethodInvestments

114000000

USD

CY2016

ehc

Healthcare Plan Expense

HealthcarePlanExpense

119000000

USD

CY2017

ehc

Healthcare Plan Expense

HealthcarePlanExpense

120800000

USD

CY2018

ehc

Healthcare Plan Expense

HealthcarePlanExpense

134900000

USD

CY2016

ehc

Income Loss From Continuing Operations Attributable To Common Shareholders Basic

IncomeLossFromContinuingOperationsAttributableToCommonShareholdersBasic

246800000

USD

CY2017

ehc

Income Loss From Continuing Operations Attributable To Common Shareholders Basic

IncomeLossFromContinuingOperationsAttributableToCommonShareholdersBasic

270600000

USD

CY2018

ehc

Income Loss From Continuing Operations Attributable To Common Shareholders Basic

IncomeLossFromContinuingOperationsAttributableToCommonShareholdersBasic

290300000

USD

CY2016

ehc

Income Loss From Continuing Operations Attributable To Common Shareholders Diluted

IncomeLossFromContinuingOperationsAttributableToCommonShareholdersDiluted

257300000

USD

CY2017

ehc

Income Loss From Continuing Operations Attributable To Common Shareholders Diluted

IncomeLossFromContinuingOperationsAttributableToCommonShareholdersDiluted

282300000

USD

CY2018

ehc

Income Loss From Continuing Operations Attributable To Common Shareholders Diluted

IncomeLossFromContinuingOperationsAttributableToCommonShareholdersDiluted

291200000

USD

CY2017Q4

ehc

Intercompany Receivablesand Investmentsin Consolidated Affiliates

IntercompanyReceivablesandInvestmentsinConsolidatedAffiliates

0

USD

CY2018Q4

ehc

Intercompany Receivablesand Investmentsin Consolidated Affiliates

IntercompanyReceivablesandInvestmentsinConsolidatedAffiliates

0

USD

CY2017Q4

ehc

Investments Cashand Restricted Cash

InvestmentsCashandRestrictedCash

178800000

USD

CY2018Q4

ehc

Investments Cashand Restricted Cash

InvestmentsCashandRestrictedCash

195500000

USD

CY2016

ehc

Liabilityfor Unpaid Claimsand Claims Adjustment Expense Discontinued Operations

LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDiscontinuedOperations

-400000

USD

CY2017

ehc

Liabilityfor Unpaid Claimsand Claims Adjustment Expense Discontinued Operations

LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDiscontinuedOperations

-500000

USD

CY2018

ehc

Liabilityfor Unpaid Claimsand Claims Adjustment Expense Discontinued Operations

LiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDiscontinuedOperations

-200000

USD

CY2018Q4

ehc

Loss Contingency Minimum Amountto Consider Accruingan Estimateof Related Legal Fees

LossContingencyMinimumAmounttoConsiderAccruinganEstimateofRelatedLegalFees

5000000

USD

CY2016

ehc

Management Fees

ManagementFees

0

USD

CY2017

ehc

Management Fees

ManagementFees

0

USD

CY2018

ehc

Management Fees

ManagementFees

0

USD

CY2018Q4

ehc

Maximum Self Insured Risk

MaximumSelfInsuredRisk

30000000

USD

CY2018Q4

ehc

Medicare Denials Percentage Collected After Appeal Including Administrative Law Judge Hearings

MedicareDenialsPercentageCollectedAfterAppealIncludingAdministrativeLawJudgeHearings

0.70

CY2016

ehc

Net Income Loss Availableto Common Stockholders

NetIncomeLossAvailabletoCommonStockholders

246800000

USD

CY2017

ehc

Net Income Loss Availableto Common Stockholders

NetIncomeLossAvailabletoCommonStockholders

270200000

USD

CY2018

ehc

Net Income Loss Availableto Common Stockholders

NetIncomeLossAvailabletoCommonStockholders

291400000

USD

CY2018Q1

ehc

Noncontrolling Interests Decreasefrom Redemptionsor Purchaseof Interests Percent

NoncontrollingInterestsDecreasefromRedemptionsorPurchaseofInterestsPercent

0.056

CY2018Q4

ehc

Number Of General Or Limited Partnerships Limited Liability Companies Or Joint Ventures

NumberOfGeneralOrLimitedPartnershipsLimitedLiabilityCompaniesOrJointVentures

4

subsidiary

CY2017Q4

ehc

Number Of Individual Claims Covered By Self Insured Risk Reserves

NumberOfIndividualClaimsCoveredBySelfInsuredRiskReserves

1000

claim

CY2018Q4

ehc

Number Of Individual Claims Covered By Self Insured Risk Reserves

NumberOfIndividualClaimsCoveredBySelfInsuredRiskReserves

1000

claim

CY2018Q4

ehc

Number Of Partially Owned Subsidiaries Nonconsolidated

NumberOfPartiallyOwnedSubsidiariesNonconsolidated

5

subsidiary

CY2018Q4

ehc

Number Of Sale Leaseback Transactions

NumberOfSaleLeasebackTransactions

3

transaction

CY2016

ehc

Operating Leases Rent Expense Other

OperatingLeasesRentExpenseOther

4000000

USD

CY2017

ehc

Operating Leases Rent Expense Other

OperatingLeasesRentExpenseOther

8900000

USD

CY2018

ehc

Operating Leases Rent Expense Other

OperatingLeasesRentExpenseOther

9100000

USD

CY2018

ehc

Ownership Percentage Of Subsidiary Guarantors

OwnershipPercentageOfSubsidiaryGuarantors

1

CY2018Q4

ehc

Percentageofassetspledgedtolendersundercreditagreement

0.70

CY2016

ehc

Proceedsfrom Paymentsfor Advanceto Affiliate

ProceedsfromPaymentsforAdvancetoAffiliate

0

USD

CY2017

ehc

Proceedsfrom Paymentsfor Advanceto Affiliate

ProceedsfromPaymentsforAdvancetoAffiliate

0

USD

CY2018

ehc

Proceedsfrom Paymentsfor Advanceto Affiliate

ProceedsfromPaymentsforAdvancetoAffiliate

0

USD

CY2017Q4

ehc

Property Plant And Equipment Fully Depreciated Assets

PropertyPlantAndEquipmentFullyDepreciatedAssets

318600000

USD

CY2018Q4

ehc

Property Plant And Equipment Fully Depreciated Assets

PropertyPlantAndEquipmentFullyDepreciatedAssets

311700000

USD

CY2018Q4

us-gaap

Additional Paid In Capital

AdditionalPaidInCapital

2588700000

USD

CY2016

us-gaap

Adjustments Related To Tax Withholding For Share Based Compensation

AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation

11600000

USD

CY2017

us-gaap

Adjustments Related To Tax Withholding For Share Based Compensation

AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation

19800000

USD

CY2018

us-gaap

Adjustments Related To Tax Withholding For Share Based Compensation

AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation

8300000

USD

CY2016

us-gaap

Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt

AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt

17300000

USD

CY2017Q4

us-gaap

Accounts Receivable Net Noncurrent

AccountsReceivableNetNoncurrent

129100000

USD

CY2018Q4

us-gaap

Accounts Receivable Net Noncurrent

AccountsReceivableNetNoncurrent

155500000

USD

CY2017Q4

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-1300000

USD

CY2018Q4

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

0

USD

CY2017Q4

us-gaap

Additional Paid In Capital

AdditionalPaidInCapital

2747400000

USD

CY2017Q4

ehc

Restricted Marketable Securities Current

RestrictedMarketableSecuritiesCurrent

17800000

USD

CY2017Q4

ehc

Restricted Marketable Securities Noncurrent

RestrictedMarketableSecuritiesNoncurrent

44200000

USD

CY2018Q4

ehc

Restricted Marketable Securities Noncurrent

RestrictedMarketableSecuritiesNoncurrent

62000000

USD

CY2016

ehc

Senior Management Bonus Program Total Costs

SeniorManagementBonusProgramTotalCosts

11200000

USD

CY2017

ehc

Senior Management Bonus Program Total Costs

SeniorManagementBonusProgramTotalCosts

14700000

USD

CY2018

ehc

Senior Management Bonus Program Total Costs

SeniorManagementBonusProgramTotalCosts

20400000

USD

CY2009Q3

ehc

Stock Issued During Period Value Warrants Exercised Shares

StockIssuedDuringPeriodValueWarrantsExercisedShares

5000000

shares

CY2017Q1

ehc

Stock Issued During Period Value Warrants Exercised Shares

StockIssuedDuringPeriodValueWarrantsExercisedShares

700000

shares

CY2017

ehc

Stock Issued During Period Value Warrants Exercised Value

StockIssuedDuringPeriodValueWarrantsExercisedValue

26600000

USD

CY2017Q4

ehc

Tax Expenseor Benefit Resultingfromthe Tax Cutsand Jobs Act

TaxExpenseorBenefitResultingfromtheTaxCutsandJobsAct

13600000

USD

CY2016

ehc

Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Decreases Resulting From Prior Period Tax Positions

UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedDecreasesResultingFromPriorPeriodTaxPositions

0

USD

CY2017

ehc

Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Decreases Resulting From Prior Period Tax Positions

UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedDecreasesResultingFromPriorPeriodTaxPositions

0

USD

CY2017

ehc

Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Decreases Resulting From Settlements With Taxing Authorities

UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedDecreasesResultingFromSettlementsWithTaxingAuthorities

0

USD

CY2016

ehc

Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Increases Resulting From Prior Period Tax Positions

UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedIncreasesResultingFromPriorPeriodTaxPositions

0

USD

CY2018

ehc

Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Increases Resulting From Prior Period Tax Positions

UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedIncreasesResultingFromPriorPeriodTaxPositions

100000

USD

CY2016

ehc

Unrecognized Tax Benefits Income Tax Penaltiesand Interest Accrued Decreases Resultingfrom Current Period Tax Positions

UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDecreasesResultingfromCurrentPeriodTaxPositions

0

USD

CY2016

ehc

Unrecognized Tax Benefits Income Tax Penaltiesand Interest Accrued Increases Resultingfrom Current Period Tax Positions

UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedIncreasesResultingfromCurrentPeriodTaxPositions

0

USD

CY2018

ehc

Unrecognized Tax Benefits Income Tax Penaltiesand Interest Accrued Reductionsto Unrecognized Tax Benefitsasa Resultofa Lapseofthe Applicable Statuteof Limitations

UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedReductionstoUnrecognizedTaxBenefitsasaResultofaLapseoftheApplicableStatuteofLimitations

0

USD

CY2017Q4

us-gaap

Accounts And Other Receivables Net Current

AccountsAndOtherReceivablesNetCurrent

12600000

USD

CY2018Q4

us-gaap

Accounts And Other Receivables Net Current

AccountsAndOtherReceivablesNetCurrent

7800000

USD

CY2017Q4

us-gaap

Accounts Payable Current

AccountsPayableCurrent

78400000

USD

CY2018Q4

us-gaap

Accounts Payable Current

AccountsPayableCurrent

90000000

USD

CY2017Q4

us-gaap

Accounts Receivable Net

AccountsReceivableNet

601200000

USD

CY2018Q4

us-gaap

Accounts Receivable Net

AccountsReceivableNet

623200000

USD

CY2017Q4

us-gaap

Accounts Receivable Net Current

AccountsReceivableNetCurrent

459500000

USD

CY2018Q4

us-gaap

Accounts Receivable Net Current

AccountsReceivableNetCurrent

459900000

USD

CY2016

us-gaap

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value

AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

21400000

USD

CY2017

us-gaap

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value

AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

21300000

USD

CY2018

us-gaap

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value

AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

28900000

USD

CY2016

us-gaap

Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities

AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities

322100000

USD

CY2017

us-gaap

Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities

AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities

307700000

USD

CY2018

us-gaap

Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities

AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities

388100000

USD

CY2016

us-gaap

Advertising Expense

AdvertisingExpense

7500000

USD

CY2017

us-gaap

Advertising Expense

AdvertisingExpense

6300000

USD

CY2018

us-gaap

Advertising Expense

AdvertisingExpense

6700000

USD

CY2016

us-gaap

Amortization Of Financing Costs And Discounts

AmortizationOfFinancingCostsAndDiscounts

13800000

USD

CY2017

us-gaap

Amortization Of Financing Costs And Discounts

AmortizationOfFinancingCostsAndDiscounts

8700000

USD

CY2018

us-gaap

Amortization Of Financing Costs And Discounts

AmortizationOfFinancingCostsAndDiscounts

4000000

USD

CY2016

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

48500000

USD

CY2017

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

49300000

USD

CY2018

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

51400000

USD

CY2016

us-gaap

Amortization Of Leased Asset

AmortizationOfLeasedAsset

21800000

USD

CY2017

us-gaap

Amortization Of Leased Asset

AmortizationOfLeasedAsset

22700000

USD

CY2018

us-gaap

Amortization Of Leased Asset

AmortizationOfLeasedAsset

24100000

USD

CY2017

us-gaap

Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount

AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

200000

shares

CY2017Q4

us-gaap

Assets

4864500000

USD

CY2018Q4

us-gaap

Assets

5175000000

USD

CY2017Q4

us-gaap

Assets Current

AssetsCurrent

702200000

USD

CY2018Q4

us-gaap

Assets Current

AssetsCurrent

662100000

USD

CY2017Q4

us-gaap

Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax

AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax

300000

USD

CY2017Q4

us-gaap

Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax

AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax

2300000

USD

CY2017Q4

us-gaap

Available For Sale Securities Amortized Cost

AvailableForSaleSecuritiesAmortizedCost

64000000

USD

CY2016

us-gaap

Available For Sale Securities Gross Realized Losses

AvailableForSaleSecuritiesGrossRealizedLosses

0

USD

CY2017

us-gaap

Available For Sale Securities Gross Realized Losses

AvailableForSaleSecuritiesGrossRealizedLosses

0

USD

CY2018

us-gaap

Available For Sale Securities Gross Realized Losses

AvailableForSaleSecuritiesGrossRealizedLosses

600000

USD

CY2017Q4

us-gaap

Available For Sale Securities Restricted

AvailableForSaleSecuritiesRestricted

62000000

USD

CY2018Q4

us-gaap

Available For Sale Securities Restricted

AvailableForSaleSecuritiesRestricted

62000000

USD

CY2017Q4

us-gaap

Capital Lease Obligations

CapitalLeaseObligations

271500000

USD

CY2018Q4

us-gaap

Capital Lease Obligations

CapitalLeaseObligations

263800000

USD

CY2017Q4

us-gaap

Capital Leased Assets Gross

CapitalLeasedAssetsGross

342900000

USD

CY2018Q4

us-gaap

Capital Leased Assets Gross

CapitalLeasedAssetsGross

351000000

USD

CY2017Q4

us-gaap

Capital Leases Balance Sheet Assets By Major Class Net

CapitalLeasesBalanceSheetAssetsByMajorClassNet

238300000

USD

CY2018Q4

us-gaap

Capital Leases Balance Sheet Assets By Major Class Net

CapitalLeasesBalanceSheetAssetsByMajorClassNet

224100000

USD

CY2018Q4

us-gaap

Capital Leases Future Minimum Payments Due

CapitalLeasesFutureMinimumPaymentsDue

455200000

USD

CY2018Q4

us-gaap

Capital Leases Future Minimum Payments Due Current

CapitalLeasesFutureMinimumPaymentsDueCurrent

36200000

USD

CY2018Q4

us-gaap

Capital Leases Future Minimum Payments Due In Five Years

CapitalLeasesFutureMinimumPaymentsDueInFiveYears

28000000

USD

CY2018Q4

us-gaap

Capital Leases Future Minimum Payments Due In Four Years

CapitalLeasesFutureMinimumPaymentsDueInFourYears

28700000

USD

CY2018Q4

us-gaap

Capital Leases Future Minimum Payments Due In Three Years

CapitalLeasesFutureMinimumPaymentsDueInThreeYears

30300000

USD

CY2018Q4

us-gaap

Capital Leases Future Minimum Payments Due In Two Years

CapitalLeasesFutureMinimumPaymentsDueInTwoYears

32300000

USD

CY2018Q4

us-gaap

Capital Leases Future Minimum Payments Due Thereafter

CapitalLeasesFutureMinimumPaymentsDueThereafter

299700000

USD

CY2018Q4

us-gaap

Capital Leases Future Minimum Payments Interest Included In Payments

CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments

191400000

USD

CY2018Q4

us-gaap

Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments

CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments

263800000

USD

CY2017Q4

us-gaap

Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation

CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation

104600000

USD

CY2018Q4

us-gaap

Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation

CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation

126900000

USD

CY2015Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

61600000

USD

CY2016Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

40500000

USD

CY2017Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

54400000

USD

CY2018Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

69200000

USD

CY2015Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

107500000

USD

CY2016Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

101400000

USD

CY2017Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

116800000

USD

CY2018Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

133500000

USD

CY2016

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect

-6100000

USD

CY2017

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect

15400000

USD

CY2018

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect

16700000

USD

CY2016

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

-6100000

USD

CY2017

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

15400000

USD

CY2018

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

16700000

USD

CY2016

us-gaap

Cash Provided By Used In Investing Activities Discontinued Operations

CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations

100000

USD

CY2017

us-gaap

Cash Provided By Used In Investing Activities Discontinued Operations

CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations

0

USD

CY2018

us-gaap

Cash Provided By Used In Investing Activities Discontinued Operations

CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations

0

USD

CY2016

us-gaap

Cash Provided By Used In Operating Activities Discontinued Operations

CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations

-700000

USD

CY2017

us-gaap

Cash Provided By Used In Operating Activities Discontinued Operations

CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations

-600000

USD

CY2018

us-gaap

Cash Provided By Used In Operating Activities Discontinued Operations

CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations

800000

USD

CY2009Q3

us-gaap

Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1

ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

41.40

CY2017Q4

us-gaap

Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1

ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

41.40

CY2017Q1

us-gaap

Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1

ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

41.40

CY2009Q3

us-gaap

Class Of Warrant Or Right Outstanding

ClassOfWarrantOrRightOutstanding

8200000

shares

CY2017Q4

us-gaap

Class Of Warrant Or Right Outstanding

ClassOfWarrantOrRightOutstanding

8200000

shares

CY2017Q1

us-gaap

Class Of Warrant Or Right Outstanding

ClassOfWarrantOrRightOutstanding

0

shares

CY2017Q4

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

USD

CY2018Q4

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

USD

CY2016

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

0.94

CY2017

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

0.98

CY2018

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

1.04

CY2017Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.01

CY2018Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.01

CY2017Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

200000000

shares

CY2018Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

200000000

shares

CY2017Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

111690547

shares

CY2018Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

112492690

shares

CY2017Q4

us-gaap

Common Stock Value

CommonStockValue

1100000

USD

CY2018Q4

us-gaap

Common Stock Value

CommonStockValue

1100000

USD

CY2016

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

247600000

USD

CY2017

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

271000000

USD

CY2018

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

292300000

USD

CY2016

us-gaap

Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

70500000

USD

CY2017

us-gaap

Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

79100000

USD

CY2018

us-gaap

Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

83100000

USD

CY2016

us-gaap

Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

318100000

USD

CY2017

us-gaap

Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

350100000

USD

CY2018

us-gaap

Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

375400000

USD

CY2018Q4

us-gaap

Contractual Obligation

ContractualObligation

871200000

USD

CY2018Q4

us-gaap

Contractual Obligation Due After Fifth Year

ContractualObligationDueAfterFifthYear

447900000

USD

CY2018Q4

us-gaap

Contractual Obligation Due In Fifth Year

ContractualObligationDueInFifthYear

63300000

USD

CY2018Q4

us-gaap

Contractual Obligation Due In Fourth Year

ContractualObligationDueInFourthYear

69700000

USD

CY2018Q4

us-gaap

Contractual Obligation Due In Next Twelve Months

ContractualObligationDueInNextTwelveMonths

107600000

USD

CY2018Q4

us-gaap

Contractual Obligation Due In Second Year

ContractualObligationDueInSecondYear

98100000

USD

CY2018Q4

us-gaap

Contractual Obligation Due In Third Year

ContractualObligationDueInThirdYear

84600000

USD

CY2017

us-gaap

Conversion Of Stock Amount Converted1

ConversionOfStockAmountConverted1

0

USD

CY2017Q4

us-gaap

Cost Method Investments

CostMethodInvestments

200000

USD

CY2018Q4

us-gaap

Cost Method Investments

CostMethodInvestments

0

USD

CY2016

us-gaap

Costs And Expenses

CostsAndExpenses

2993800000

USD

CY2017

us-gaap

Costs And Expenses

CostsAndExpenses

3264500000

USD

CY2018

us-gaap

Costs And Expenses

CostsAndExpenses

3647700000

USD

CY2016

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

16100000

USD

CY2017

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

72200000

USD

CY2018

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

103800000

USD

CY2016

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

31000000

USD

CY2017

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

85000000

USD

CY2018

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

128000000

USD

CY2016

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

14900000

USD

CY2017

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

12800000

USD

CY2018

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

24200000

USD

CY2017Q4

us-gaap

Debt And Capital Lease Obligations

DebtAndCapitalLeaseObligations

2577700000

USD

CY2018Q4

us-gaap

Debt And Capital Lease Obligations

DebtAndCapitalLeaseObligations

2514400000

USD

CY2016

us-gaap

Debt Conversion Converted Instrument Amount1

DebtConversionConvertedInstrumentAmount1

0

USD

CY2017

us-gaap

Debt Conversion Converted Instrument Amount1

DebtConversionConvertedInstrumentAmount1

319400000

USD

CY2018

us-gaap

Debt Conversion Converted Instrument Amount1

DebtConversionConvertedInstrumentAmount1

0

USD

CY2018Q4

us-gaap

Decrease In Unrecognized Tax Benefits Is Reasonably Possible

DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible

500000

USD

CY2016

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

130500000

USD

CY2017

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

58400000

USD

CY2018

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-13700000

USD

CY2017Q4

us-gaap

Deferred Income Tax Assets Net

DeferredIncomeTaxAssetsNet

34400000

USD

CY2018Q4

us-gaap

Deferred Income Tax Assets Net

DeferredIncomeTaxAssetsNet

42900000

USD

CY2016

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

132900000

USD

CY2017

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

60800000

USD

CY2018

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-9100000

USD

CY2017Q4

us-gaap

Deferred Income Tax Liabilities

DeferredIncomeTaxLiabilities

120500000

USD

CY2018Q4

us-gaap

Deferred Income Tax Liabilities

DeferredIncomeTaxLiabilities

103900000

USD

CY2017Q4

us-gaap

Deferred Rent Credit Noncurrent

DeferredRentCreditNoncurrent

11200000

USD

CY2018Q4

us-gaap

Deferred Rent Credit Noncurrent

DeferredRentCreditNoncurrent

12100000

USD

CY2016

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

2400000

USD

CY2017

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

2400000

USD

CY2018

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

4600000

USD

CY2017Q4

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

190700000

USD

CY2018Q4

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

180500000

USD

CY2017Q4

us-gaap

Deferred Tax Assets Liabilities Net

DeferredTaxAssetsLiabilitiesNet

34400000

USD

CY2018Q4

us-gaap

Deferred Tax Assets Liabilities Net

DeferredTaxAssetsLiabilitiesNet

42900000

USD

CY2017Q4

us-gaap

Deferred Tax Assets Net

DeferredTaxAssetsNet

154900000

USD

CY2018Q4

us-gaap

Deferred Tax Assets Net

DeferredTaxAssetsNet

146800000

USD

CY2017Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards

DeferredTaxAssetsOperatingLossCarryforwards

77300000

USD

CY2018Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards

DeferredTaxAssetsOperatingLossCarryforwards

66000000

USD

CY2017Q4

us-gaap

Deferred Tax Assets Other

DeferredTaxAssetsOther

500000

USD

CY2018Q4

us-gaap

Deferred Tax Assets Other

DeferredTaxAssetsOther

600000

USD

CY2017Q4

us-gaap

Deferred Tax Assets Property Plant And Equipment

DeferredTaxAssetsPropertyPlantAndEquipment

36300000

USD

CY2018Q4

us-gaap

Deferred Tax Assets Property Plant And Equipment

DeferredTaxAssetsPropertyPlantAndEquipment

30800000

USD

CY2017Q4

us-gaap

Deferred Tax Assets Tax Credit Carryforwards

DeferredTaxAssetsTaxCreditCarryforwards

2800000

USD

CY2018Q4

us-gaap

Deferred Tax Assets Tax Credit Carryforwards

DeferredTaxAssetsTaxCreditCarryforwards

4700000

USD

CY2017Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

19500000

USD

CY2018Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

33000000

USD

CY2017Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts

14000000

USD

CY2018Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts

6100000

USD

CY2017Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther

20400000

USD

CY2018Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther

22500000

USD

CY2017Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance

19900000

USD

CY2018Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance

16800000

USD

CY2017Q4

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

35800000

USD

CY2018Q4

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

33700000

USD

CY2017Q4

us-gaap

Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets

DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets

80000000

USD

CY2018Q4

us-gaap

Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets

DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets

88500000

USD

CY2017Q4

us-gaap

Deferred Tax Liabilities Investments

DeferredTaxLiabilitiesInvestments

11400000

USD

CY2018Q4

us-gaap

Deferred Tax Liabilities Investments

DeferredTaxLiabilitiesInvestments

15200000

USD

CY2017Q4

us-gaap

Deferred Tax Liabilities Other

DeferredTaxLiabilitiesOther

200000

USD

CY2018Q4

us-gaap

Deferred Tax Liabilities Other

DeferredTaxLiabilitiesOther

200000

USD

CY2017Q4

us-gaap

Deferred Tax Liabilities Tax Deferred Income

DeferredTaxLiabilitiesTaxDeferredIncome

28900000

USD

CY2018Q4

us-gaap

Deferred Tax Liabilities Tax Deferred Income

DeferredTaxLiabilitiesTaxDeferredIncome

0

USD

CY2016

us-gaap

Depreciation

102300000

USD

CY2017

us-gaap

Depreciation

111800000

USD

CY2018

us-gaap

Depreciation

124200000

USD

CY2016

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

172600000

USD

CY2017

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

183800000

USD

CY2018

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

199700000

USD

CY2016

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

84900000

USD

CY2017

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

95200000

USD

CY2018

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

103700000

USD

CY2017Q4

us-gaap

Due To Affiliate Noncurrent

DueToAffiliateNoncurrent

0

USD

CY2018Q4

us-gaap

Due To Affiliate Noncurrent

DueToAffiliateNoncurrent

0

USD

CY2016

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

2.77

CY2017Q1

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.75

CY2017Q2

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.70

CY2017Q3

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.67

CY2017Q4

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.77

CY2017

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

2.88

CY2018Q1

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.85

CY2018Q2

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.93

CY2018Q3

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.90

CY2018Q4

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.29

CY2018

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

2.98

CY2016

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

2.59

CY2017Q1

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.70

CY2017Q2

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.70

CY2017Q3

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.67

CY2017Q4

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.76

CY2017

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

2.84

CY2018Q1

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.84

CY2018Q2

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.92

CY2018Q3

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.89

CY2018Q4

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.28

CY2018

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

2.93

CY2016

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.340

CY2017

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.294

CY2018

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.241

CY2016

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.350

CY2017

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.350

CY2018

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.210

CY2016

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

0.001

CY2017

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

0.004

CY2018

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

-0.004

CY2016

us-gaap

Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate

EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate

0

CY2017

us-gaap

Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate

EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate

-0.028

CY2018

us-gaap

Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate

EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate

0

CY2016

us-gaap

Effective Income Tax Rate Reconciliation Minority Interest Income Expense

EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense

-0.044

CY2017

us-gaap

Effective Income Tax Rate Reconciliation Minority Interest Income Expense

EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense

-0.046

CY2018

us-gaap

Effective Income Tax Rate Reconciliation Minority Interest Income Expense

EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense

-0.032

CY2016

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

-0.005

CY2017

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

-0.003

CY2018

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

-0.001

CY2016

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.038

CY2017

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.035

CY2018

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.045

CY2016

us-gaap

Effective Income Tax Rate Reconciliation Tax Settlements

EffectiveIncomeTaxRateReconciliationTaxSettlements

0

CY2017

us-gaap

Effective Income Tax Rate Reconciliation Tax Settlements

EffectiveIncomeTaxRateReconciliationTaxSettlements

0

CY2018

us-gaap

Effective Income Tax Rate Reconciliation Tax Settlements

EffectiveIncomeTaxRateReconciliationTaxSettlements

0.027

CY2017Q4

us-gaap

Employee Related Liabilities Current

EmployeeRelatedLiabilitiesCurrent

172100000

USD

CY2018Q4

us-gaap

Employee Related Liabilities Current

EmployeeRelatedLiabilitiesCurrent

188400000

USD

CY2018Q4

us-gaap

Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options

EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions

1600000

USD

CY2017Q4

us-gaap

Equity Method Investment Aggregate Cost

EquityMethodInvestmentAggregateCost

900000

USD

CY2018Q4

us-gaap

Equity Method Investment Aggregate Cost

EquityMethodInvestmentAggregateCost

900000

USD

CY2016

us-gaap

Equity Method Investment Dividends Or Distributions

EquityMethodInvestmentDividendsOrDistributions

8500000

USD

CY2017

us-gaap

Equity Method Investment Dividends Or Distributions

EquityMethodInvestmentDividendsOrDistributions

8600000

USD

CY2018

us-gaap

Equity Method Investment Dividends Or Distributions

EquityMethodInvestmentDividendsOrDistributions

8300000

USD

CY2017Q4

us-gaap

Equity Method Investment Summarized Financial Information Assets

EquityMethodInvestmentSummarizedFinancialInformationAssets

28400000

USD

CY2018Q4

us-gaap

Equity Method Investment Summarized Financial Information Assets

EquityMethodInvestmentSummarizedFinancialInformationAssets

27700000

USD

CY2017Q4

us-gaap

Equity Method Investment Summarized Financial Information Current Assets

EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets

10100000

USD

CY2018Q4

us-gaap

Equity Method Investment Summarized Financial Information Current Assets

EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets

9900000

USD

CY2018Q4

us-gaap

Finite Lived Intangible Assets Accumulated Amortization

FiniteLivedIntangibleAssetsAccumulatedAmortization

288200000

USD

CY2018Q4

us-gaap

Finite Lived Intangible Assets Amortization Expense Next Twelve Months

FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

56900000

USD

CY2018Q4

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Five

FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

27000000

USD

CY2018Q4

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Four

FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

29600000

USD

CY2017Q4

us-gaap

Equity Method Investment Summarized Financial Information Current Liabilities

EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities

2700000

USD

CY2018Q4

us-gaap

Equity Method Investment Summarized Financial Information Current Liabilities

EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities

1400000

USD

CY2016

us-gaap

Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items

EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems

20500000

USD

CY2017

us-gaap

Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items

EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems

17000000

USD

CY2018

us-gaap

Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items

EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems

17100000

USD

CY2017Q4

us-gaap

Equity Method Investment Summarized Financial Information Liabilities And Equity

EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity

28400000

USD

CY2018Q4

us-gaap

Equity Method Investment Summarized Financial Information Liabilities And Equity

EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity

27700000

USD

CY2017Q4

us-gaap

Equity Method Investment Summarized Financial Information Minority Interest

EquityMethodInvestmentSummarizedFinancialInformationMinorityInterest

13800000

USD

CY2018Q4

us-gaap

Equity Method Investment Summarized Financial Information Minority Interest

EquityMethodInvestmentSummarizedFinancialInformationMinorityInterest

14000000

USD

CY2016

us-gaap

Equity Method Investment Summarized Financial Information Net Income Loss

EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss

20500000

USD

CY2017

us-gaap

Equity Method Investment Summarized Financial Information Net Income Loss

EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss

17000000

USD

CY2018

us-gaap

Equity Method Investment Summarized Financial Information Net Income Loss

EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss

17100000

USD

CY2017Q4

us-gaap

Equity Method Investment Summarized Financial Information Noncurrent Assets

EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets

18300000

USD

CY2018Q4

us-gaap

Equity Method Investment Summarized Financial Information Noncurrent Assets

EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets

17800000

USD

CY2017Q4

us-gaap

Equity Method Investment Summarized Financial Information Noncurrent Liabilities

EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities

200000

USD

CY2018Q4

us-gaap

Equity Method Investment Summarized Financial Information Noncurrent Liabilities

EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities

100000

USD

CY2016

us-gaap

Equity Method Investment Summarized Financial Information Revenue

EquityMethodInvestmentSummarizedFinancialInformationRevenue

44800000

USD

CY2017

us-gaap

Equity Method Investment Summarized Financial Information Revenue

EquityMethodInvestmentSummarizedFinancialInformationRevenue

40900000

USD

CY2018

us-gaap

Equity Method Investment Summarized Financial Information Revenue

EquityMethodInvestmentSummarizedFinancialInformationRevenue

42600000

USD

CY2017Q4

us-gaap

Equity Method Investment Underlying Equity In Net Assets

EquityMethodInvestmentUnderlyingEquityInNetAssets

11700000

USD

CY2018Q4

us-gaap

Equity Method Investment Underlying Equity In Net Assets

EquityMethodInvestmentUnderlyingEquityInNetAssets

12200000

USD

CY2017Q4

us-gaap

Equity Method Investments

EquityMethodInvestments

11700000

USD

CY2018Q4

us-gaap

Equity Method Investments

EquityMethodInvestments

12200000

USD

CY2018

us-gaap

Equity Securities Fv Ni Unrealized Gain Loss

EquitySecuritiesFvNiUnrealizedGainLoss

1700000

USD

CY2016

us-gaap

Extinguishment Of Debt Gain Loss Net Of Tax

ExtinguishmentOfDebtGainLossNetOfTax

0

USD

CY2017

us-gaap

Extinguishment Of Debt Gain Loss Net Of Tax

ExtinguishmentOfDebtGainLossNetOfTax

6200000

USD

CY2018

us-gaap

Extinguishment Of Debt Gain Loss Net Of Tax

ExtinguishmentOfDebtGainLossNetOfTax

0

USD

CY2017Q4

us-gaap

Finite Lived Intangible Assets Accumulated Amortization

FiniteLivedIntangibleAssetsAccumulatedAmortization

305200000

USD

CY2018Q4

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Three

FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

35700000

USD

CY2018Q4

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Two

FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

43300000

USD

CY2017Q4

us-gaap

Finite Lived Intangible Assets Gross

FiniteLivedIntangibleAssetsGross

708300000

USD

CY2018Q4

us-gaap

Finite Lived Intangible Assets Gross

FiniteLivedIntangibleAssetsGross

731600000

USD

CY2017Q4

us-gaap

Finite Lived Intangible Assets Net

FiniteLivedIntangibleAssetsNet

403100000

USD

CY2018Q4

us-gaap

Finite Lived Intangible Assets Net

FiniteLivedIntangibleAssetsNet

443400000

USD

CY2016

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

-7400000

USD

CY2017

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

-10700000

USD

CY2018

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

0

USD

CY2016

us-gaap

General And Administrative Expense

GeneralAndAdministrativeExpense

133400000

USD

CY2017

us-gaap

General And Administrative Expense

GeneralAndAdministrativeExpense

171700000

USD

CY2018

us-gaap

General And Administrative Expense

GeneralAndAdministrativeExpense

220200000

USD

CY2015Q4

us-gaap

Goodwill

1890100000

USD

CY2016Q4

us-gaap

Goodwill

1927200000

USD

CY2017Q4

us-gaap

Goodwill

1972600000

USD

CY2018Q4

us-gaap

Goodwill

2100800000

USD

CY2016

us-gaap

Goodwill Acquired During Period

GoodwillAcquiredDuringPeriod

51400000

USD

CY2017

us-gaap

Goodwill Acquired During Period

GoodwillAcquiredDuringPeriod

45400000

USD

CY2018

us-gaap

Goodwill Acquired During Period

GoodwillAcquiredDuringPeriod

128200000

USD

CY2018Q4

us-gaap

Goodwill Impaired Accumulated Impairment Loss

GoodwillImpairedAccumulatedImpairmentLoss

0

USD

CY2016

us-gaap

Goodwill Impairment Loss

GoodwillImpairmentLoss

0

USD

CY2017

us-gaap

Goodwill Impairment Loss

GoodwillImpairmentLoss

0

USD

CY2018

us-gaap

Goodwill Impairment Loss

GoodwillImpairmentLoss

0

USD

CY2016

us-gaap

Goodwill Written Off Related To Sale Of Business Unit

GoodwillWrittenOffRelatedToSaleOfBusinessUnit

14300000

USD

CY2016

us-gaap

Income Loss From Continuing Operations

IncomeLossFromContinuingOperations

247600000

USD

CY2017

us-gaap

Income Loss From Continuing Operations

IncomeLossFromContinuingOperations

271500000

USD

CY2018

us-gaap

Income Loss From Continuing Operations

IncomeLossFromContinuingOperations

291200000

USD

CY2016

us-gaap

Income Loss From Continuing Operations Attributable To Noncontrolling Entity

IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity

70500000

USD

CY2017

us-gaap

Income Loss From Continuing Operations Attributable To Noncontrolling Entity

IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity

79100000

USD

CY2018

us-gaap

Income Loss From Continuing Operations Attributable To Noncontrolling Entity

IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity

83100000

USD

CY2016

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

482000000

USD

CY2017

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

496400000

USD

CY2018

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

493200000

USD

CY2016

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

318100000

USD

CY2017Q1

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

84700000

USD

CY2017Q2

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

79200000

USD

CY2017Q3

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

85200000

USD

CY2017Q4

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

101500000

USD

CY2017

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

350600000

USD

CY2018Q1

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

105700000

USD

CY2018Q2

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

113000000

USD

CY2018Q3

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

109400000

USD

CY2018Q4

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

46200000

USD

CY2018

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

374300000

USD

CY2016

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

2.77

CY2017Q1

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

0.75

CY2017Q2

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

0.70

CY2017Q3

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

0.67

CY2017Q4

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

0.77

CY2017

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

2.88

CY2018Q1

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

0.86

CY2018Q2

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

0.93

CY2018Q3

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

0.90

CY2018Q4

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

0.27

CY2018

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

2.97

CY2016

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

2.59

CY2017Q1

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

0.70

CY2018Q4

us-gaap

Self Insurance Reserve Noncurrent

SelfInsuranceReserveNoncurrent

119600000

USD

CY2016

us-gaap

Share Based Compensation

ShareBasedCompensation

27400000

USD

CY2017Q2

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

0.70

CY2017Q3

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

0.67

CY2017Q4

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

0.76

CY2017

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

2.84

CY2018Q1

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

0.85

CY2018Q2

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

0.92

CY2018Q3

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

0.89

CY2018Q4

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

0.26

CY2018

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

2.92

CY2016

us-gaap

Income Loss From Discontinued Operations Net Of Tax

IncomeLossFromDiscontinuedOperationsNetOfTax

0

USD

CY2017Q1

us-gaap

Income Loss From Discontinued Operations Net Of Tax

IncomeLossFromDiscontinuedOperationsNetOfTax

-300000

USD

CY2017Q2

us-gaap

Income Loss From Discontinued Operations Net Of Tax

IncomeLossFromDiscontinuedOperationsNetOfTax

200000

USD

CY2017Q3

us-gaap

Income Loss From Discontinued Operations Net Of Tax

IncomeLossFromDiscontinuedOperationsNetOfTax

-100000

USD

CY2017Q4

us-gaap

Income Loss From Discontinued Operations Net Of Tax

IncomeLossFromDiscontinuedOperationsNetOfTax

-200000

USD

CY2017

us-gaap

Income Loss From Discontinued Operations Net Of Tax

IncomeLossFromDiscontinuedOperationsNetOfTax

-400000

USD

CY2018Q1

us-gaap

Income Loss From Discontinued Operations Net Of Tax

IncomeLossFromDiscontinuedOperationsNetOfTax

-500000

USD

CY2018Q2

us-gaap

Income Loss From Discontinued Operations Net Of Tax

IncomeLossFromDiscontinuedOperationsNetOfTax

200000

USD

CY2018Q3

us-gaap

Income Loss From Discontinued Operations Net Of Tax

IncomeLossFromDiscontinuedOperationsNetOfTax

-100000

USD

CY2018Q4

us-gaap

Income Loss From Discontinued Operations Net Of Tax

IncomeLossFromDiscontinuedOperationsNetOfTax

1500000

USD

CY2018

us-gaap

Income Loss From Discontinued Operations Net Of Tax

IncomeLossFromDiscontinuedOperationsNetOfTax

1100000

USD

CY2016

us-gaap

Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity

IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

0

USD

CY2017

us-gaap

Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity

IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

-400000

USD

CY2018

us-gaap

Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity

IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

1100000

USD

CY2016

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

0.00

CY2017Q1

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

0.00

CY2017Q2

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

0.00

CY2017Q3

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

0.00

CY2017Q4

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

0.00

CY2017

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

0.00

CY2018Q1

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

-0.01

CY2018Q2

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

0.00

CY2018Q3

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

0.00

CY2018Q4

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

0.02

CY2018

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

0.01

CY2016

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

0.00

CY2017Q1

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

0.00

CY2017Q2

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

0.00

CY2017Q3

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

0.00

CY2017Q4

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

0.00

CY2017

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

0.00

CY2018Q1

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

-0.01

CY2018Q2

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

0.00

CY2018Q3

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

0.00

CY2018Q4

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

0.02

CY2018

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

0.01

CY2016

us-gaap

Income Loss From Equity Method Investments

IncomeLossFromEquityMethodInvestments

9800000

USD

CY2017

us-gaap

Income Loss From Equity Method Investments

IncomeLossFromEquityMethodInvestments

8000000

USD

CY2018

us-gaap

Income Loss From Equity Method Investments

IncomeLossFromEquityMethodInvestments

8700000

USD

CY2016

us-gaap

Income Loss From Subsidiaries Before Tax

IncomeLossFromSubsidiariesBeforeTax

0

USD

CY2017

us-gaap

Income Loss From Subsidiaries Before Tax

IncomeLossFromSubsidiariesBeforeTax

0

USD

CY2018

us-gaap

Income Loss From Subsidiaries Before Tax

IncomeLossFromSubsidiariesBeforeTax

0

USD

CY2016

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

163900000

USD

CY2017Q1

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

39700000

USD

CY2017Q2

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

28600000

USD

CY2017Q3

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

43100000

USD

CY2017Q4

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

34400000

USD

CY2017

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

145800000

USD

CY2018Q1

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

30000000

USD

CY2018Q2

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

29300000

USD

CY2018Q3

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

30200000

USD

CY2018Q4

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

29400000

USD

CY2018

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

118900000

USD

CY2016

us-gaap

Income Taxes Paid

IncomeTaxesPaid

33300000

USD

CY2017

us-gaap

Income Taxes Paid

IncomeTaxesPaid

96400000

USD

CY2018

us-gaap

Income Taxes Paid

IncomeTaxesPaid

115400000

USD

CY2016

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

6300000

USD

CY2017

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

7500000

USD

CY2018

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

6600000

USD

CY2016

us-gaap

Increase Decrease In Accounts Receivable

IncreaseDecreaseInAccountsReceivable

66300000

USD

CY2017

us-gaap

Increase Decrease In Accounts Receivable

IncreaseDecreaseInAccountsReceivable

31500000

USD

CY2018

us-gaap

Increase Decrease In Accounts Receivable

IncreaseDecreaseInAccountsReceivable

-7000000

USD

CY2016

us-gaap

Increase Decrease In Accrued Salaries

IncreaseDecreaseInAccruedSalaries

21400000

USD

CY2017

us-gaap

Increase Decrease In Accrued Salaries

IncreaseDecreaseInAccruedSalaries

24400000

USD

CY2018

us-gaap

Increase Decrease In Accrued Salaries

IncreaseDecreaseInAccruedSalaries

14800000

USD

CY2016

us-gaap

Increase Decrease In Due To Related Parties

IncreaseDecreaseInDueToRelatedParties

0

USD

CY2016

us-gaap

Increase Decrease In Other Operating Liabilities

IncreaseDecreaseInOtherOperatingLiabilities

11800000

USD

CY2017

us-gaap

Increase Decrease In Other Operating Liabilities

IncreaseDecreaseInOtherOperatingLiabilities

4800000

USD

CY2018

us-gaap

Increase Decrease In Other Operating Liabilities

IncreaseDecreaseInOtherOperatingLiabilities

6100000

USD

CY2016

us-gaap

Increase Decrease In Prepaid Deferred Expense And Other Assets

IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

3300000

USD

CY2017

us-gaap

Increase Decrease In Prepaid Deferred Expense And Other Assets

IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

12600000

USD

CY2018

us-gaap

Increase Decrease In Prepaid Deferred Expense And Other Assets

IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

-11500000

USD

CY2016

us-gaap

Incremental Common Shares Attributable To Conversion Of Debt Securities

IncrementalCommonSharesAttributableToConversionOfDebtSecurities

8500000

shares

CY2017

us-gaap

Incremental Common Shares Attributable To Conversion Of Debt Securities

IncrementalCommonSharesAttributableToConversionOfDebtSecurities

4000000

shares

CY2018

us-gaap

Incremental Common Shares Attributable To Conversion Of Debt Securities

IncrementalCommonSharesAttributableToConversionOfDebtSecurities

0

shares

CY2016

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

1900000

shares

CY2017

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

1600000

shares

CY2018

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

1900000

shares

CY2017Q4

us-gaap

Intangible Assets Net Excluding Goodwill

IntangibleAssetsNetExcludingGoodwill

403100000

USD

CY2018Q4

us-gaap

Intangible Assets Net Excluding Goodwill

IntangibleAssetsNetExcludingGoodwill

443400000

USD

CY2016

us-gaap

Interest Costs Capitalized

InterestCostsCapitalized

2000000

USD

CY2017

us-gaap

Interest Costs Capitalized

InterestCostsCapitalized

3700000

USD

CY2018

us-gaap

Interest Costs Capitalized

InterestCostsCapitalized

6000000

USD

CY2017Q4

us-gaap

Liabilities

3248200000

USD

CY2018Q4

us-gaap

Liabilities

3356300000

USD

CY2016

us-gaap

Interest Expense

InterestExpense

172100000

USD

CY2017

us-gaap

Interest Expense

InterestExpense

154400000

USD

CY2018

us-gaap

Interest Expense

InterestExpense

147300000

USD

CY2016

us-gaap

Interest On Convertible Debt Net Of Tax

InterestOnConvertibleDebtNetOfTax

9700000

USD

CY2017

us-gaap

Interest On Convertible Debt Net Of Tax

InterestOnConvertibleDebtNetOfTax

4600000

USD

CY2018

us-gaap

Interest On Convertible Debt Net Of Tax

InterestOnConvertibleDebtNetOfTax

0

USD

CY2016

us-gaap

Interest Paid

InterestPaid

164300000

USD

CY2017

us-gaap

Interest Paid

InterestPaid

150500000

USD

CY2018

us-gaap

Interest Paid

InterestPaid

149600000

USD

CY2017Q4

us-gaap

Interest Payable Current

InterestPayableCurrent

24700000

USD

CY2018Q4

us-gaap

Interest Payable Current

InterestPayableCurrent

24400000

USD

CY2017Q4

us-gaap

Investments In Affiliates Subsidiaries Associates And Joint Ventures

InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures

11900000

USD

CY2018Q4

us-gaap

Investments In Affiliates Subsidiaries Associates And Joint Ventures

InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures

12200000

USD

CY2016

us-gaap

Labor And Related Expense

LaborAndRelatedExpense

1985900000

USD

CY2017

us-gaap

Labor And Related Expense

LaborAndRelatedExpense

2154600000

USD

CY2018

us-gaap

Labor And Related Expense

LaborAndRelatedExpense

2354000000

USD

CY2016

us-gaap

Lease And Rental Expense

LeaseAndRentalExpense

71300000

USD

CY2017

us-gaap

Lease And Rental Expense

LeaseAndRentalExpense

73500000

USD

CY2018

us-gaap

Lease And Rental Expense

LeaseAndRentalExpense

78000000

USD

CY2017Q4

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

4864500000

USD

CY2018Q4

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

5175000000

USD

CY2017Q4

us-gaap

Liabilities Current

LiabilitiesCurrent

517500000

USD

CY2018Q4

us-gaap

Liabilities Current

LiabilitiesCurrent

672500000

USD

CY2015Q4

us-gaap

Liability For Claims And Claims Adjustment Expense

LiabilityForClaimsAndClaimsAdjustmentExpense

142100000

USD

CY2016Q4

us-gaap

Liability For Claims And Claims Adjustment Expense

LiabilityForClaimsAndClaimsAdjustmentExpense

171400000

USD

CY2017Q4

us-gaap

Liability For Claims And Claims Adjustment Expense

LiabilityForClaimsAndClaimsAdjustmentExpense

171000000

USD

CY2018Q4

us-gaap

Liability For Claims And Claims Adjustment Expense

LiabilityForClaimsAndClaimsAdjustmentExpense

160900000

USD

CY2016

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1

5000000

USD

CY2017

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1

5000000

USD

CY2018

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1

7000000

USD

CY2016

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1

23500000

USD

CY2017

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1

35100000

USD

CY2018

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1

27000000

USD

CY2015Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Net

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet

115500000

USD

CY2016Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Net

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet

130000000

USD

CY2017Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Net

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet

131100000

USD

CY2018Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Net

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet

135300000

USD

CY2016

us-gaap

Litigation Settlement Expense

LitigationSettlementExpense

0

USD

CY2017

us-gaap

Litigation Settlement Expense

LitigationSettlementExpense

0

USD

CY2018

us-gaap

Litigation Settlement Expense

LitigationSettlementExpense

52000000

USD

CY2017Q4

us-gaap

Long Term Debt And Capital Lease Obligations

LongTermDebtAndCapitalLeaseObligations

2545400000

USD

CY2018Q4

us-gaap

Long Term Debt And Capital Lease Obligations

LongTermDebtAndCapitalLeaseObligations

2478600000

USD

CY2017Q4

us-gaap

Long Term Debt And Capital Lease Obligations Current

LongTermDebtAndCapitalLeaseObligationsCurrent

32300000

USD

CY2018Q4

us-gaap

Long Term Debt And Capital Lease Obligations Current

LongTermDebtAndCapitalLeaseObligationsCurrent

35800000

USD

CY2018Q4

us-gaap

Minimum Lease Payments Sale Leaseback Transactions Thereafter

MinimumLeasePaymentsSaleLeasebackTransactionsThereafter

82200000

USD

CY2018Q4

us-gaap

Minimum Lease Payments Sale Leaseback Transactions Within Five Years

MinimumLeasePaymentsSaleLeasebackTransactionsWithinFiveYears

6800000

USD

CY2018Q4

us-gaap

Minimum Lease Payments Sale Leaseback Transactions Within Four Years

MinimumLeasePaymentsSaleLeasebackTransactionsWithinFourYears

7500000

USD

CY2018Q4

us-gaap

Minimum Lease Payments Sale Leaseback Transactions Within One Year

MinimumLeasePaymentsSaleLeasebackTransactionsWithinOneYear

7500000

USD

CY2018Q4

us-gaap

Minimum Lease Payments Sale Leaseback Transactions Within Three Years

MinimumLeasePaymentsSaleLeasebackTransactionsWithinThreeYears

7600000

USD

CY2018Q4

us-gaap

Minimum Lease Payments Sale Leaseback Transactions Within Two Years

MinimumLeasePaymentsSaleLeasebackTransactionsWithinTwoYears

7500000

USD

CY2017Q4

us-gaap

Minority Interest

MinorityInterest

242900000

USD

CY2018Q4

us-gaap

Minority Interest

MinorityInterest

280300000

USD

CY2016

us-gaap

Minority Interest Change In Redemption Value

MinorityInterestChangeInRedemptionValue

-10900000

USD

CY2017

us-gaap

Minority Interest Change In Redemption Value

MinorityInterestChangeInRedemptionValue

-67000000

USD

CY2018

us-gaap

Minority Interest Change In Redemption Value

MinorityInterestChangeInRedemptionValue

-91000000

USD

CY2016

us-gaap

Minority Interest Decrease From Distributions To Noncontrolling Interest Holders

MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

54200000

USD

CY2017

us-gaap

Minority Interest Decrease From Distributions To Noncontrolling Interest Holders

MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

50500000

USD

CY2018

us-gaap

Minority Interest Decrease From Distributions To Noncontrolling Interest Holders

MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

71100000

USD

CY2016

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-416400000

USD

CY2017

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-359900000

USD

CY2018

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-321200000

USD

CY2016

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-229900000

USD

CY2017

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-283000000

USD

CY2018

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-424500000

USD

CY2016

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

640200000

USD

CY2017

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

658300000

USD

CY2018

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

762400000

USD

CY2016

us-gaap

Net Income Loss

NetIncomeLoss

247600000

USD

CY2017Q1

us-gaap

Net Income Loss

NetIncomeLoss

66800000

USD

CY2017Q2

us-gaap

Net Income Loss

NetIncomeLoss

63000000

USD

CY2017Q3

us-gaap

Net Income Loss

NetIncomeLoss

65900000

USD

CY2017Q4

us-gaap

Net Income Loss

NetIncomeLoss

75400000

USD

CY2017

us-gaap

Net Income Loss

NetIncomeLoss

271100000

USD

CY2018Q1

us-gaap

Net Income Loss

NetIncomeLoss

83800000

USD

CY2018Q2

us-gaap

Net Income Loss

NetIncomeLoss

91800000

USD

CY2018Q3

us-gaap

Net Income Loss

NetIncomeLoss

88600000

USD

CY2018Q4

us-gaap

Net Income Loss

NetIncomeLoss

28100000

USD

CY2018

us-gaap

Net Income Loss

NetIncomeLoss

292300000

USD

CY2016

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

70500000

USD

CY2017Q1

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

17600000

USD

CY2017Q2

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

16400000

USD

CY2017Q3

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

19200000

USD

CY2017Q4

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

25900000

USD

CY2017

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

79100000

USD

CY2018Q1

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

21400000

USD

CY2018Q2

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

21400000

USD

CY2018Q3

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

20700000

USD

CY2018Q4

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

19600000

USD

CY2018

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

83100000

USD

CY2016

us-gaap

Net Income Loss Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossAttributableToNonredeemableNoncontrollingInterest

56400000

USD

CY2017

us-gaap

Net Income Loss Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossAttributableToNonredeemableNoncontrollingInterest

61200000

USD

CY2018

us-gaap

Net Income Loss Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossAttributableToNonredeemableNoncontrollingInterest

69200000

USD

CY2016

us-gaap

Net Income Loss Attributable To Redeemable Noncontrolling Interest

NetIncomeLossAttributableToRedeemableNoncontrollingInterest

14100000

USD

CY2017

us-gaap

Net Income Loss Attributable To Redeemable Noncontrolling Interest

NetIncomeLossAttributableToRedeemableNoncontrollingInterest

17900000

USD

CY2018

us-gaap

Net Income Loss Attributable To Redeemable Noncontrolling Interest

NetIncomeLossAttributableToRedeemableNoncontrollingInterest

13900000

USD

CY2016

us-gaap

Net Income Loss Available To Common Stockholders Diluted

NetIncomeLossAvailableToCommonStockholdersDiluted

257300000

USD

CY2017

us-gaap

Net Income Loss Available To Common Stockholders Diluted

NetIncomeLossAvailableToCommonStockholdersDiluted

281900000

USD

CY2018

us-gaap

Net Income Loss Available To Common Stockholders Diluted

NetIncomeLossAvailableToCommonStockholdersDiluted

292300000

USD

CY2016

us-gaap

Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest

304000000

USD

CY2017

us-gaap

Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest

332300000

USD

CY2018

us-gaap

Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest

361500000

USD

CY2017Q4

us-gaap

Notes Payable Related Parties Noncurrent

NotesPayableRelatedPartiesNoncurrent

0

USD

CY2018Q4

us-gaap

Notes Payable Related Parties Noncurrent

NotesPayableRelatedPartiesNoncurrent

0

USD

CY2017Q4

us-gaap

Notes Receivable Related Parties Noncurrent

NotesReceivableRelatedPartiesNoncurrent

0

USD

CY2018Q4

us-gaap

Notes Receivable Related Parties Noncurrent

NotesReceivableRelatedPartiesNoncurrent

0

USD

CY2018Q4

us-gaap

Number Of States In Which Entity Operates

NumberOfStatesInWhichEntityOperates

36

state

CY2017Q1

us-gaap

Operating Income Loss

OperatingIncomeLoss

147100000

USD

CY2017Q2

us-gaap

Operating Income Loss

OperatingIncomeLoss

141300000

USD

CY2017Q3

us-gaap

Operating Income Loss

OperatingIncomeLoss

145200000

USD

CY2017Q4

us-gaap

Operating Income Loss

OperatingIncomeLoss

144700000

USD

CY2017

us-gaap

Operating Income Loss

OperatingIncomeLoss

578300000

USD

CY2018Q1

us-gaap

Operating Income Loss

OperatingIncomeLoss

150000000

USD

CY2018Q2

us-gaap

Operating Income Loss

OperatingIncomeLoss

157300000

USD

CY2018Q3

us-gaap

Operating Income Loss

OperatingIncomeLoss

154500000

USD

CY2018Q4

us-gaap

Operating Income Loss

OperatingIncomeLoss

93400000

USD

CY2018

us-gaap

Operating Income Loss

OperatingIncomeLoss

555200000

USD

CY2018Q4

us-gaap

Operating Leases Future Minimum Payments Due

OperatingLeasesFutureMinimumPaymentsDue

416000000

USD

CY2018Q4

us-gaap

Other Commitment Due After Fifth Year

OtherCommitmentDueAfterFifthYear

6500000

USD

CY2018Q4

us-gaap

Other Commitment Due In Fifth Year

OtherCommitmentDueInFifthYear

7600000

USD

CY2018Q4

us-gaap

Other Commitment Due In Fourth Year

OtherCommitmentDueInFourthYear

9500000

USD

CY2018Q4

us-gaap

Operating Leases Future Minimum Payments Due Current

OperatingLeasesFutureMinimumPaymentsDueCurrent

71400000

USD

CY2018Q4

us-gaap

Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals

OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals

2600000

USD

CY2018Q4

us-gaap

Operating Leases Future Minimum Payments Due In Five Years

OperatingLeasesFutureMinimumPaymentsDueInFiveYears

35300000

USD

CY2018Q4

us-gaap

Operating Leases Future Minimum Payments Due In Four Years

OperatingLeasesFutureMinimumPaymentsDueInFourYears

41000000

USD

CY2018Q4

us-gaap

Operating Leases Future Minimum Payments Due In Three Years

OperatingLeasesFutureMinimumPaymentsDueInThreeYears

54300000

USD

CY2018Q4

us-gaap

Operating Leases Future Minimum Payments Due In Two Years

OperatingLeasesFutureMinimumPaymentsDueInTwoYears

65800000

USD

CY2018Q4

us-gaap

Operating Leases Future Minimum Payments Due Thereafter

OperatingLeasesFutureMinimumPaymentsDueThereafter

148200000

USD

CY2016

us-gaap

Operating Leases Income Statement Sublease Revenue

OperatingLeasesIncomeStatementSubleaseRevenue

4100000

USD

CY2017

us-gaap

Operating Leases Income Statement Sublease Revenue

OperatingLeasesIncomeStatementSubleaseRevenue

2900000

USD

CY2018

us-gaap

Operating Leases Income Statement Sublease Revenue

OperatingLeasesIncomeStatementSubleaseRevenue

3000000

USD

CY2016

us-gaap

Operating Leases Rent Expense Contingent Rentals

OperatingLeasesRentExpenseContingentRentals

29400000

USD

CY2017

us-gaap

Operating Leases Rent Expense Contingent Rentals

OperatingLeasesRentExpenseContingentRentals

24100000

USD

CY2018

us-gaap

Operating Leases Rent Expense Contingent Rentals

OperatingLeasesRentExpenseContingentRentals

24900000

USD

CY2016

us-gaap

Operating Leases Rent Expense Minimum Rentals

OperatingLeasesRentExpenseMinimumRentals

62600000

USD

CY2017

us-gaap

Operating Leases Rent Expense Minimum Rentals

OperatingLeasesRentExpenseMinimumRentals

66500000

USD

CY2018

us-gaap

Operating Leases Rent Expense Minimum Rentals

OperatingLeasesRentExpenseMinimumRentals

69800000

USD

CY2016

us-gaap

Operating Leases Rent Expense Net

OperatingLeasesRentExpenseNet

96000000

USD

CY2017

us-gaap

Operating Leases Rent Expense Net

OperatingLeasesRentExpenseNet

99500000

USD

CY2018

us-gaap

Operating Leases Rent Expense Net

OperatingLeasesRentExpenseNet

103800000

USD

CY2016

us-gaap

Origination Of Notes Receivable From Related Parties

OriginationOfNotesReceivableFromRelatedParties

0

USD

CY2017Q4

us-gaap

Other Assets Noncurrent

OtherAssetsNoncurrent

235100000

USD

CY2018Q4

us-gaap

Other Assets Noncurrent

OtherAssetsNoncurrent

291000000

USD

CY2018Q4

us-gaap

Other Commitment Due In Next Twelve Months

OtherCommitmentDueInNextTwelveMonths

45900000

USD

CY2018Q4

us-gaap

Other Commitment Due In Second Year

OtherCommitmentDueInSecondYear

44000000

USD

CY2018Q4

us-gaap

Other Commitment Due In Third Year

OtherCommitmentDueInThirdYear

28100000

USD

CY2016

us-gaap

Other Comprehensive Income Loss Before Tax

OtherComprehensiveIncomeLossBeforeTax

100000

USD

CY2017

us-gaap

Other Comprehensive Income Loss Before Tax

OtherComprehensiveIncomeLossBeforeTax

-100000

USD

CY2018

us-gaap

Other Comprehensive Income Loss Before Tax

OtherComprehensiveIncomeLossBeforeTax

0

USD

CY2016

us-gaap

Other Comprehensive Income Loss Net Of Tax

OtherComprehensiveIncomeLossNetOfTax

0

USD

CY2017

us-gaap

Other Comprehensive Income Loss Net Of Tax

OtherComprehensiveIncomeLossNetOfTax

-100000

USD

CY2018

us-gaap

Other Comprehensive Income Loss Net Of Tax

OtherComprehensiveIncomeLossNetOfTax

0

USD

CY2016

us-gaap

Other Comprehensive Income Loss Tax

OtherComprehensiveIncomeLossTax

100000

USD

CY2017

us-gaap

Other Comprehensive Income Loss Tax

OtherComprehensiveIncomeLossTax

0

USD

CY2018

us-gaap

Other Comprehensive Income Loss Tax

OtherComprehensiveIncomeLossTax

0

USD

CY2016

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax

100000

USD

CY2017

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax

-100000

USD

CY2018

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax

0

USD

CY2016

us-gaap

Other Cost And Expense Operating

OtherCostAndExpenseOperating

490600000

USD

CY2017

us-gaap

Other Cost And Expense Operating

OtherCostAndExpenseOperating

531600000

USD

CY2018

us-gaap

Other Cost And Expense Operating

OtherCostAndExpenseOperating

585100000

USD

CY2017Q4

us-gaap

Other Liabilities Current

OtherLiabilitiesCurrent

210000000

USD

CY2018Q4

us-gaap

Other Liabilities Current

OtherLiabilitiesCurrent

333900000

USD

CY2017

us-gaap

Prior Period Reclassification Adjustment

PriorPeriodReclassificationAdjustment

-45900000

USD

CY2018

us-gaap

Prior Period Reclassification Adjustment

PriorPeriodReclassificationAdjustment

-40500000

USD

CY2016

us-gaap

Proceeds From Contributions From Affiliates

ProceedsFromContributionsFromAffiliates

3500000

USD

CY2017

us-gaap

Proceeds From Contributions From Affiliates

ProceedsFromContributionsFromAffiliates

20800000

USD

CY2018

us-gaap

Proceeds From Contributions From Affiliates

ProceedsFromContributionsFromAffiliates

12600000

USD

CY2016

us-gaap

Proceeds From Income Tax Refunds

ProceedsFromIncomeTaxRefunds

1400000

USD

CY2017

us-gaap

Proceeds From Income Tax Refunds

ProceedsFromIncomeTaxRefunds

1900000

USD

CY2018

us-gaap

Proceeds From Income Tax Refunds

ProceedsFromIncomeTaxRefunds

600000

USD

CY2017Q4

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

75200000

USD

CY2018

us-gaap

Payments Of Dividends Common Stock

PaymentsOfDividendsCommonStock

100800000

USD

CY2018Q4

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

85600000

USD

CY2016

us-gaap

Other Noncash Income Expense

OtherNoncashIncomeExpense

-100000

USD

CY2017

us-gaap

Other Noncash Income Expense

OtherNoncashIncomeExpense

-3400000

USD

CY2018

us-gaap

Other Noncash Income Expense

OtherNoncashIncomeExpense

-9200000

USD

CY2016

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

2900000

USD

CY2017

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

4100000

USD

CY2018

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

2200000

USD

CY2016

us-gaap

Other Than Temporary Impairment Losses Investments Availableforsale Securities

OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities

0

USD

CY2017

us-gaap

Other Than Temporary Impairment Losses Investments Availableforsale Securities

OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities

0

USD

CY2016

us-gaap

Partners Capital Account Contributions

PartnersCapitalAccountContributions

19600000

USD

CY2017

us-gaap

Partners Capital Account Contributions

PartnersCapitalAccountContributions

46200000

USD

CY2018

us-gaap

Partners Capital Account Contributions

PartnersCapitalAccountContributions

38800000

USD

CY2016

us-gaap

Payments For Proceeds From Other Investing Activities

PaymentsForProceedsFromOtherInvestingActivities

1700000

USD

CY2017

us-gaap

Payments For Proceeds From Other Investing Activities

PaymentsForProceedsFromOtherInvestingActivities

7200000

USD

CY2018

us-gaap

Payments For Proceeds From Other Investing Activities

PaymentsForProceedsFromOtherInvestingActivities

8800000

USD

CY2016

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

65600000

USD

CY2017

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

38100000

USD

CY2018

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

0

USD

CY2016

us-gaap

Payments For Software

PaymentsForSoftware

25200000

USD

CY2017

us-gaap

Payments For Software

PaymentsForSoftware

19200000

USD

CY2018

us-gaap

Payments For Software

PaymentsForSoftware

16000000

USD

CY2016

us-gaap

Payments Of Dividends Common Stock

PaymentsOfDividendsCommonStock

83800000

USD

CY2017

us-gaap

Payments Of Dividends Common Stock

PaymentsOfDividendsCommonStock

91500000

USD

CY2016

us-gaap

Payments Related To Tax Withholding For Share Based Compensation

PaymentsRelatedToTaxWithholdingForShareBasedCompensation

11600000

USD

CY2017

us-gaap

Payments Related To Tax Withholding For Share Based Compensation

PaymentsRelatedToTaxWithholdingForShareBasedCompensation

19800000

USD

CY2018

us-gaap

Payments Related To Tax Withholding For Share Based Compensation

PaymentsRelatedToTaxWithholdingForShareBasedCompensation

8300000

USD

CY2016

us-gaap

Payments To Acquire Businesses Net Of Cash Acquired

PaymentsToAcquireBusinessesNetOfCashAcquired

48100000

USD

CY2017

us-gaap

Payments To Acquire Businesses Net Of Cash Acquired

PaymentsToAcquireBusinessesNetOfCashAcquired

38800000

USD

CY2018

us-gaap

Payments To Acquire Businesses Net Of Cash Acquired

PaymentsToAcquireBusinessesNetOfCashAcquired

143900000

USD

CY2018Q1

us-gaap

Payments To Acquire Interest In Subsidiaries And Affiliates

PaymentsToAcquireInterestInSubsidiariesAndAffiliates

65000000

USD

CY2016

us-gaap

Payments To Acquire Interest In Subsidiaries And Affiliates

PaymentsToAcquireInterestInSubsidiariesAndAffiliates

0

USD

CY2017

us-gaap

Payments To Acquire Interest In Subsidiaries And Affiliates

PaymentsToAcquireInterestInSubsidiariesAndAffiliates

0

USD

CY2018

us-gaap

Payments To Acquire Interest In Subsidiaries And Affiliates

PaymentsToAcquireInterestInSubsidiariesAndAffiliates

65100000

USD

CY2016

us-gaap

Payments To Acquire Property Plant And Equipment

PaymentsToAcquirePropertyPlantAndEquipment

177700000

USD

CY2017

us-gaap

Payments To Acquire Property Plant And Equipment

PaymentsToAcquirePropertyPlantAndEquipment

225800000

USD

CY2018

us-gaap

Payments To Acquire Property Plant And Equipment

PaymentsToAcquirePropertyPlantAndEquipment

254500000

USD

CY2016

us-gaap

Payments To Acquire Restricted Investments

PaymentsToAcquireRestrictedInvestments

1300000

USD

CY2017

us-gaap

Payments To Acquire Restricted Investments

PaymentsToAcquireRestrictedInvestments

8500000

USD

CY2018

us-gaap

Payments To Acquire Restricted Investments

PaymentsToAcquireRestrictedInvestments

13300000

USD

CY2016

us-gaap

Payments To Minority Shareholders

PaymentsToMinorityShareholders

64900000

USD

CY2017

us-gaap

Payments To Minority Shareholders

PaymentsToMinorityShareholders

51900000

USD

CY2018

us-gaap

Payments To Minority Shareholders

PaymentsToMinorityShareholders

75400000

USD

CY2017Q4

us-gaap

Prepaid Expense And Other Assets Current

PrepaidExpenseAndOtherAssetsCurrent

113300000

USD

CY2018Q4

us-gaap

Prepaid Expense And Other Assets Current

PrepaidExpenseAndOtherAssetsCurrent

66200000

USD

CY2016

us-gaap

Proceeds From Long Term Lines Of Credit

ProceedsFromLongTermLinesOfCredit

335000000

USD

CY2017

us-gaap

Proceeds From Long Term Lines Of Credit

ProceedsFromLongTermLinesOfCredit

273300000

USD

CY2018

us-gaap

Proceeds From Long Term Lines Of Credit

ProceedsFromLongTermLinesOfCredit

325000000

USD

CY2016

us-gaap

Proceeds From Notes Payable

ProceedsFromNotesPayable

0

USD

CY2017

us-gaap

Proceeds From Notes Payable

ProceedsFromNotesPayable

0

USD

CY2018

us-gaap

Proceeds From Notes Payable

ProceedsFromNotesPayable

13200000

USD

CY2016

us-gaap

Proceeds From Payments For Other Financing Activities

ProceedsFromPaymentsForOtherFinancingActivities

-600000

USD

CY2017

us-gaap

Proceeds From Payments For Other Financing Activities

ProceedsFromPaymentsForOtherFinancingActivities

-3800000

USD

CY2018

us-gaap

Proceeds From Payments For Other Financing Activities

ProceedsFromPaymentsForOtherFinancingActivities

6100000

USD

CY2016

us-gaap

Proceeds From Related Party Debt

ProceedsFromRelatedPartyDebt

0

USD

CY2016

us-gaap

Proceeds From Sale Of Property Plant And Equipment

ProceedsFromSaleOfPropertyPlantAndEquipment

23900000

USD

CY2017

us-gaap

Proceeds From Sale Of Property Plant And Equipment

ProceedsFromSaleOfPropertyPlantAndEquipment

12300000

USD

CY2018

us-gaap

Proceeds From Sale Of Property Plant And Equipment

ProceedsFromSaleOfPropertyPlantAndEquipment

400000

USD

CY2016

us-gaap

Proceeds From Sale Of Restricted Investments

ProceedsFromSaleOfRestrictedInvestments

100000

USD

CY2017

us-gaap

Proceeds From Sale Of Restricted Investments

ProceedsFromSaleOfRestrictedInvestments

4200000

USD

CY2018

us-gaap

Proceeds From Sale Of Restricted Investments

ProceedsFromSaleOfRestrictedInvestments

11600000

USD

CY2017Q1

us-gaap

Proceeds From Warrant Exercises

ProceedsFromWarrantExercises

26700000

USD

CY2016

us-gaap

Proceeds From Warrant Exercises

ProceedsFromWarrantExercises

0

USD

CY2017

us-gaap

Proceeds From Warrant Exercises

ProceedsFromWarrantExercises

26600000

USD

CY2018

us-gaap

Proceeds From Warrant Exercises

ProceedsFromWarrantExercises

0

USD

CY2016

us-gaap

Profit Loss

ProfitLoss

318100000

USD

CY2017Q1

us-gaap

Profit Loss

ProfitLoss

84400000

USD

CY2017Q2

us-gaap

Profit Loss

ProfitLoss

79400000

USD

CY2017Q3

us-gaap

Profit Loss

ProfitLoss

85100000

USD

CY2017Q4

us-gaap

Profit Loss

ProfitLoss

101300000

USD

CY2017

us-gaap

Profit Loss

ProfitLoss

350200000

USD

CY2018Q1

us-gaap

Profit Loss

ProfitLoss

105200000

USD

CY2018Q2

us-gaap

Profit Loss

ProfitLoss

113200000

USD

CY2018Q3

us-gaap

Profit Loss

ProfitLoss

109300000

USD

CY2018Q4

us-gaap

Profit Loss

ProfitLoss

47700000

USD

CY2018

us-gaap

Profit Loss

ProfitLoss

375400000

USD

CY2017Q4

us-gaap

Property Plant And Equipment Gross

PropertyPlantAndEquipmentGross

2453600000

USD

CY2018Q4

us-gaap

Property Plant And Equipment Gross

PropertyPlantAndEquipmentGross

2631300000

USD

CY2017Q4

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

1517100000

USD

CY2018Q4

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

1634800000

USD

CY2017Q4

us-gaap

Receivables Net Current

ReceivablesNetCurrent

472100000

USD

CY2018Q4

us-gaap

Receivables Net Current

ReceivablesNetCurrent

467700000

USD

CY2017Q4

us-gaap

Redeemable Noncontrolling Interest Equity Carrying Amount

RedeemableNoncontrollingInterestEquityCarryingAmount

220900000

USD

CY2018Q4

us-gaap

Redeemable Noncontrolling Interest Equity Carrying Amount

RedeemableNoncontrollingInterestEquityCarryingAmount

261700000

USD

CY2017Q4

us-gaap

Redeemable Noncontrolling Interest Equity Fair Value

RedeemableNoncontrollingInterestEquityFairValue

220900000

USD

CY2018Q4

us-gaap

Redeemable Noncontrolling Interest Equity Fair Value

RedeemableNoncontrollingInterestEquityFairValue

261700000

USD

CY2015Q4

us-gaap

Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

26600000

USD

CY2016Q4

us-gaap

Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

41400000

USD

CY2017Q4

us-gaap

Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

39900000

USD

CY2018Q4

us-gaap

Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

25600000

USD

CY2016

us-gaap

Repayment Of Notes Receivable From Related Parties

RepaymentOfNotesReceivableFromRelatedParties

0

USD

CY2017

us-gaap

Repayment Of Notes Receivable From Related Parties

RepaymentOfNotesReceivableFromRelatedParties

0

USD

CY2018

us-gaap

Repayment Of Notes Receivable From Related Parties

RepaymentOfNotesReceivableFromRelatedParties

0

USD

CY2016

us-gaap

Repayments Of Long Term Capital Lease Obligations

RepaymentsOfLongTermCapitalLeaseObligations

13300000

USD

CY2017

us-gaap

Repayments Of Long Term Capital Lease Obligations

RepaymentsOfLongTermCapitalLeaseObligations

15300000

USD

CY2018

us-gaap

Repayments Of Long Term Capital Lease Obligations

RepaymentsOfLongTermCapitalLeaseObligations

17900000

USD

CY2016

us-gaap

Repayments Of Long Term Debt

RepaymentsOfLongTermDebt

202100000

USD

CY2017

us-gaap

Repayments Of Long Term Debt

RepaymentsOfLongTermDebt

129900000

USD

CY2018

us-gaap

Repayments Of Long Term Debt

RepaymentsOfLongTermDebt

20600000

USD

CY2016

us-gaap

Repayments Of Long Term Lines Of Credit

RepaymentsOfLongTermLinesOfCredit

313000000

USD

CY2017

us-gaap

Repayments Of Long Term Lines Of Credit

RepaymentsOfLongTermLinesOfCredit

330300000

USD

CY2018

us-gaap

Repayments Of Long Term Lines Of Credit

RepaymentsOfLongTermLinesOfCredit

390000000

USD

CY2016

us-gaap

Repayments Of Related Party Debt

RepaymentsOfRelatedPartyDebt

0

USD

CY2017

us-gaap

Repayments Of Related Party Debt

RepaymentsOfRelatedPartyDebt

0

USD

CY2018

us-gaap

Repayments Of Related Party Debt

RepaymentsOfRelatedPartyDebt

0

USD

CY2017Q4

us-gaap

Restricted Cash And Cash Equivalents

RestrictedCashAndCashEquivalents

62400000

USD

CY2018Q4

us-gaap

Restricted Cash And Cash Equivalents

RestrictedCashAndCashEquivalents

64300000

USD

CY2017Q4

us-gaap

Restricted Cash And Cash Equivalents At Carrying Value

RestrictedCashAndCashEquivalentsAtCarryingValue

62400000

USD

CY2018Q4

us-gaap

Restricted Cash And Cash Equivalents At Carrying Value

RestrictedCashAndCashEquivalentsAtCarryingValue

59000000

USD

CY2017Q4

us-gaap

Restricted Cash And Cash Equivalents Noncurrent

RestrictedCashAndCashEquivalentsNoncurrent

62400000

USD

CY2018Q4

us-gaap

Restricted Cash And Cash Equivalents Noncurrent

RestrictedCashAndCashEquivalentsNoncurrent

64300000

USD

CY2015Q4

us-gaap

Restricted Cash Current

RestrictedCashCurrent

45900000

USD

CY2016Q4

us-gaap

Restricted Cash Current

RestrictedCashCurrent

60900000

USD

CY2017Q4

us-gaap

Restricted Cash Current

RestrictedCashCurrent

62400000

USD

CY2018Q4

us-gaap

Restricted Cash Current

RestrictedCashCurrent

59000000

USD

CY2016Q4

us-gaap

Restricted Cash Noncurrent

RestrictedCashNoncurrent

0

USD

CY2017Q4

us-gaap

Restricted Cash Noncurrent

RestrictedCashNoncurrent

0

USD

CY2018Q4

us-gaap

Restricted Cash Noncurrent

RestrictedCashNoncurrent

5300000

USD

CY2017Q4

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

-1176200000

USD

CY2018Q4

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

-885200000

USD

CY2016

us-gaap

Revenue From Contract With Customer Excluding Assessed Tax

RevenueFromContractWithCustomerExcludingAssessedTax

3642600000

USD

CY2017Q1

us-gaap

Revenue From Contract With Customer Excluding Assessed Tax

RevenueFromContractWithCustomerExcludingAssessedTax

957100000

USD

CY2017Q2

us-gaap

Revenue From Contract With Customer Excluding Assessed Tax

RevenueFromContractWithCustomerExcludingAssessedTax

966400000

USD

CY2017Q3

us-gaap

Revenue From Contract With Customer Excluding Assessed Tax

RevenueFromContractWithCustomerExcludingAssessedTax

981600000

USD

CY2017Q4

us-gaap

Revenue From Contract With Customer Excluding Assessed Tax

RevenueFromContractWithCustomerExcludingAssessedTax

1008800000

USD

CY2017

us-gaap

Revenue From Contract With Customer Excluding Assessed Tax

RevenueFromContractWithCustomerExcludingAssessedTax

3913900000

USD

CY2018Q1

us-gaap

Revenue From Contract With Customer Excluding Assessed Tax

RevenueFromContractWithCustomerExcludingAssessedTax

1046000000

USD

CY2018Q2

us-gaap

Revenue From Contract With Customer Excluding Assessed Tax

RevenueFromContractWithCustomerExcludingAssessedTax

1067700000

USD

CY2018Q3

us-gaap

Revenue From Contract With Customer Excluding Assessed Tax

RevenueFromContractWithCustomerExcludingAssessedTax

1067600000

USD

CY2018Q4

us-gaap

Revenue From Contract With Customer Excluding Assessed Tax

RevenueFromContractWithCustomerExcludingAssessedTax

1096000000

USD

CY2018

us-gaap

Revenue From Contract With Customer Excluding Assessed Tax

RevenueFromContractWithCustomerExcludingAssessedTax

4277300000

USD

CY2017Q4

us-gaap

Self Insurance Reserve Current

SelfInsuranceReserveCurrent

60900000

USD

CY2018Q4

us-gaap

Self Insurance Reserve Current

SelfInsuranceReserveCurrent

41300000

USD

CY2017Q4

us-gaap

Self Insurance Reserve Noncurrent

SelfInsuranceReserveNoncurrent

110100000

USD

CY2017

us-gaap

Share Based Compensation

ShareBasedCompensation

47700000

USD

CY2018

us-gaap

Share Based Compensation

ShareBasedCompensation

85900000

USD

CY2018Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

317000

shares

CY2018Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

27.65

CY2016

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

9100000

USD

CY2017

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

29000000

USD

CY2018

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

5200000

USD

CY2018

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod

0

shares

CY2018

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod

0

shares

CY2018

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

95000

shares

CY2016

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

11.55

CY2017

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

11.55

CY2018

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

14.57

CY2018Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

14200000

USD

CY2017Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

557000

shares

CY2018Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

537000

shares

CY2017Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

30.53

CY2018Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

35.22

CY2018

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

27.79

CY2018

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice

0.00

CY2018

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice

0.00

CY2018

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

53.79

CY2018Q4

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

10800000

USD

CY2018

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

P4Y1M

CY2018

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

P5Y11M

CY2017

us-gaap

Stock Issued During Period Shares Conversion Of Convertible Securities

StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities

8900000

shares

CY2018

us-gaap

Stock Issued During Period Shares Stock Options Exercised

StockIssuedDuringPeriodSharesStockOptionsExercised

115000

shares

CY2017

us-gaap

Stock Issued During Period Value Conversion Of Convertible Securities

StockIssuedDuringPeriodValueConversionOfConvertibleSecurities

328200000

USD

CY2016

us-gaap

Stock Issued During Period Value Stock Options Exercised

StockIssuedDuringPeriodValueStockOptionsExercised

5300000

USD

CY2017

us-gaap

Stock Issued During Period Value Stock Options Exercised

StockIssuedDuringPeriodValueStockOptionsExercised

1100000

USD

CY2018

us-gaap

Stock Issued During Period Value Stock Options Exercised

StockIssuedDuringPeriodValueStockOptionsExercised

3200000

USD

CY2017Q4

us-gaap

Stockholders Equity

StockholdersEquity

1152500000

USD

CY2018Q4

us-gaap

Stockholders Equity

StockholdersEquity

1276700000

USD

CY2015Q4

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

765400000

USD

CY2016Q4

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

910600000

USD

CY2017Q4

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

1395400000

USD

CY2018Q4

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

1557000000

USD

CY2016

us-gaap

Stockholders Equity Other

StockholdersEquityOther

-4800000

USD

CY2017

us-gaap

Stockholders Equity Other

StockholdersEquityOther

300000

USD

CY2018

us-gaap

Stockholders Equity Other

StockholdersEquityOther

-3300000

USD

CY2016

us-gaap

Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense

SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense

43500000

USD

CY2017

us-gaap

Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense

SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense

44700000

USD

CY2018

us-gaap

Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense

SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense

47100000

USD

CY2016

us-gaap

Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense

SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense

-100000

USD

CY2017

us-gaap

Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense

SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense

-3000000

USD

CY2018

us-gaap

Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense

SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense

-8700000

USD

CY2016

us-gaap

Supplies Expense

SuppliesExpense

140000000

USD

CY2017

us-gaap

Supplies Expense

SuppliesExpense

149300000

USD

CY2018

us-gaap

Supplies Expense

SuppliesExpense

158700000

USD

CY2017Q4

us-gaap

Treasury Stock Shares

TreasuryStockShares

13385019

shares

CY2018Q4

us-gaap

Treasury Stock Shares

TreasuryStockShares

13566209

shares

CY2017Q4

us-gaap

Treasury Stock Value

TreasuryStockValue

418500000

USD

CY2018Q4

us-gaap

Treasury Stock Value

TreasuryStockValue

427900000

USD

CY2016

us-gaap

Treasury Stock Value Acquired Cost Method

TreasuryStockValueAcquiredCostMethod

65600000

USD

CY2017

us-gaap

Treasury Stock Value Acquired Cost Method

TreasuryStockValueAcquiredCostMethod

38100000

USD

CY2016

us-gaap

Undistributed Earnings Loss Allocated To Participating Securities Basic

UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic

800000

USD

CY2017

us-gaap

Undistributed Earnings Loss Allocated To Participating Securities Basic

UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic

900000

USD

CY2018

us-gaap

Undistributed Earnings Loss Allocated To Participating Securities Basic

UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic

900000

USD

CY2015Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

2900000

USD

CY2016Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

2800000

USD

CY2017Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

300000

USD

CY2018Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

900000

USD

CY2016

us-gaap

Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions

UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions

100000

USD

CY2016

us-gaap

Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions

UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions

400000

USD

CY2017

us-gaap

Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions

UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions

400000

USD

CY2017

us-gaap

Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities

UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities

2100000

USD

CY2015Q4

us-gaap

Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued

UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued

0

USD

CY2016Q4

us-gaap

Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued

UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued

0

USD

CY2017Q4

us-gaap

Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued

UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued

0

USD

CY2018Q4

us-gaap

Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued

UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued

100000

USD

CY2016

us-gaap

Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions

UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions

100000

USD

CY2017

us-gaap

Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions

UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions

51300000

USD

CY2016

us-gaap

Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions

UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions

300000

USD

CY2018

us-gaap

Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions

UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions

800000

USD

CY2017

us-gaap

Unrecognized Tax Benefits Period Increase Decrease

UnrecognizedTaxBenefitsPeriodIncreaseDecrease

2500000

USD

CY2018

us-gaap

Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations

UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations

200000

USD

CY2016Q4

us-gaap

Unrecognized Tax Benefits That Would Impact Effective Tax Rate

UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate

2800000

USD

CY2017Q4

us-gaap

Unrecognized Tax Benefits That Would Impact Effective Tax Rate

UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate

300000

USD

CY2018Q4

us-gaap

Unrecognized Tax Benefits That Would Impact Effective Tax Rate

UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate

900000

USD

CY2016

us-gaap

Valuation Allowance Deferred Tax Asset Change In Amount

ValuationAllowanceDeferredTaxAssetChangeInAmount

-300000

USD

CY2017

us-gaap

Valuation Allowance Deferred Tax Asset Change In Amount

ValuationAllowanceDeferredTaxAssetChangeInAmount

-7900000

USD

CY2018

us-gaap

Valuation Allowance Deferred Tax Asset Change In Amount

ValuationAllowanceDeferredTaxAssetChangeInAmount

2100000

USD

CY2016

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

99500000

shares

CY2017

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

99300000

shares

CY2018

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

99800000

shares

CY2016

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

89100000

shares

CY2017

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

93700000

shares

CY2018

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

97900000

shares

CY2018

us-gaap

Revenue Recognition Accounting Policy Gross And Net Revenue Disclosure

RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Net Operating Revenues—</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Net operating revenues</font><font style="font-family:inherit;font-size:10pt;"> disaggregated by payor source and segment are as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:13px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.61013645224172%;border-collapse:collapse;text-align:left;"><tr><td colspan="36" rowspan="1"></td></tr><tr><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Inpatient Rehabilitation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Home Health and Hospice</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Consolidated</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medicare</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,451.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,313.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,187.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">794.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">662.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">565.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,246.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,976.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,753.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medicare Advantage</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">306.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">261.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">226.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">395.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">335.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">285.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Managed care</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">343.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">335.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">325.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">376.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">364.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">351.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medicaid</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other third-party payors</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Workers’ compensation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patients</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,346.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,141.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,964.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">931.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">772.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">678.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,277.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,913.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,642.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We record </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Net operating revenues</font><font style="font-family:inherit;font-size:10pt;"> on an accrual basis using our best estimate of the transaction price for the type of service provided to the patient. Our estimate of the transaction price includes estimates of price concessions for such items as contractual allowances, potential adjustments that may arise from payment and other reviews, and uncollectible amounts. Our accounting systems calculate contractual allowances on a patient-by-patient basis based on the rates in effect for each primary third-party payor. Adjustments related to payment reviews by third-party payors or their agents are based on our historical experience and success rates in the claims adjudication process.</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">Estimates for uncollectible amounts are based on the aging of our accounts receivable, our historical collection experience for each type of payor, and other relevant factors. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management continually reviews the revenue transaction price estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms that result from contract renegotiations and renewals. Due to complexities involved in determining amounts ultimately due under reimbursement arrangements with third-party payors, which are often subject to interpretation, we may receive reimbursement for healthcare services authorized and provided that is different from our estimates, and such differences could be material. In addition, laws and regulations governing the Medicare and Medicaid programs are complex, subject to interpretation, and are routinely modified for provider reimbursement. All healthcare providers participating in the Medicare and Medicaid programs are required to meet certain financial reporting requirements. Federal regulations require submission of annual cost reports covering medical costs and expenses associated with the services provided under each hospital, home health, and hospice provider number to program beneficiaries. Annual cost reports required under the Medicare and Medicaid programs are subject to routine audits, which may result in adjustments to the amounts ultimately determined to be due to Encompass Health under these reimbursement programs. These audits often require several years to reach the final determination of amounts earned under the programs. If actual results are not consistent with our assumptions and judgments, we may be exposed to gains or losses that could be material. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Centers for Medicare and Medicaid Services (“CMS”) has been granted authority to suspend payments, in whole or in part, to Medicare providers if CMS possesses reliable information an overpayment, fraud, or willful misrepresentation exists. If CMS suspects payments are being made as the result of fraud or misrepresentation, CMS may suspend payment at any time without providing prior notice to us. The initial suspension period is limited to 180 days. However, the payment suspension period can be extended almost indefinitely if the matter is under investigation by the United States Department of Health and Human Services Office of Inspector General (the “HHS-OIG”) or the United States Department of Justice (the “DOJ”). Therefore, we are unable to predict if or when we may be subject to a suspension of payments by the Medicare and/or Medicaid programs, the possible length of the suspension period, or the potential cash flow impact of a payment suspension. Any such suspension would adversely impact our financial position, results of operations, and cash flows. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to legislative directives and authorizations from Congress, CMS has developed and instituted various Medicare audit programs under which CMS contracts with private companies to conduct claims and medical record audits. As a matter of course, we undertake significant efforts through training and education to ensure compliance with Medicare requirements. However, audits may lead to assertions we have been underpaid or overpaid by Medicare or submitted improper claims in some instances, require us to incur additional costs to respond to requests for records and defend the validity of payments and claims, and ultimately require us to refund any amounts determined to have been overpaid. In some circumstances auditors assert the authority to extrapolate denial rationales to large pools of claims not actually audited, which could increase the impact of the audit. We cannot predict when or how these audit programs will affect us.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medicare Administrative Contractors (“MACs”), under programs known as “widespread probes,” have conducted pre-payment claim reviews of our Medicare billings and in some cases denied payment for certain diagnosis codes. The majority of the denials we have encountered in these probes relate to determinations regarding medical necessity and provision of therapy services. We dispute, or “appeal,” most of these denials, and for claims we choose to take to administrative law judge hearings, we have historically experienced a success rate of approximately</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">70%</font><font style="font-family:inherit;font-size:10pt;">. This historical success rate is a component of our estimate of transaction price as discussed above. The resolution of these disputes can take in excess of three years, and we cannot provide assurance as to our ongoing and future success of these disputes. When the amount collected related to denied claims differs from the amount previously estimated, these collection differences are recorded as an adjustment to </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Net operating revenues</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2017, CMS announced the Targeted Probe and Educate (“TPE”) initiative. Under the TPE initiative, MACs use data analysis to identify healthcare providers with high claim error rates and items and services that have high national error rates. Once a MAC selects a provider for claims review, the initial volume of claims review is limited to 20 to 40 claims. The TPE initiative includes up to three rounds of claims review if necessary with corresponding provider education and a subsequent period to allow for improvement. If results do not improve sufficiently after three rounds, the MAC may refer the provider to CMS for further action, which may include extrapolation of error rates to a broader universe of claims or referral to a ZPIC or RAC (defined below). We cannot predict the impact of the TPE initiative on our ability to collect claims on a timely basis.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with CMS approved and announced Recovery Audit Contractors (“RACs”) audits related to inpatient rehabilitation facilities (“IRFs”), we received requests from </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">2013</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">2018</font><font style="font-family:inherit;font-size:10pt;"> to review certain patient files for discharges occurring from </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">2010</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">2018</font><font style="font-family:inherit;font-size:10pt;">. These RAC audits are focused on identifying Medicare claims that may contain improper payments. RAC contractors must have CMS approval before conducting these focused reviews which cover issues ranging from billing documentation to medical necessity. Medical necessity is an assessment by an independent physician of a patient’s ability to tolerate and benefit from intensive multi-disciplinary therapy provided in an IRF setting.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CMS has also established contractors known as the Zone Program Integrity Contractors (“ZPICs”). These contractors conduct audits with a focus on potential fraud and abuse issues. Like the RACs, the ZPICs conduct audits and have the ability to refer matters to the HHS-OIG or the DOJ. Unlike RACs, however, ZPICs do not receive a specific financial incentive based on the amount of the error as a result of ZPIC audits. We have, from time to time, received ZPIC record requests which have resulted in claim denials on paid claims. We have appealed substantially all ZPIC denials arising from these audits using the same process we follow for appealing other denials by contractors. CMS has announced its intention to rename ZPICs as Unified Program Integrity Contractors.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To date, the Medicare claims that are subject to these post-payment audit requests represent less than </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">1%</font><font style="font-family:inherit;font-size:10pt;"> of our Medicare patient discharges from </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">2010</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">2018</font><font style="font-family:inherit;font-size:10pt;">, and not all of these patient file requests have resulted in payment denial determinations by the audit contractor. Because we have confidence in the medical judgment of both the referring and admitting physicians who assess the treatment needs of their patients, we have appealed substantially all claim denials arising from these audits using the same process we follow for appealing denials of certain diagnosis codes by MACs. Due to the delays announced by CMS in the related adjudication process, we believe the resolution of any claims that are subsequently denied as a result of these claim audits could take in excess of three years. In addition, because we have limited experience with ZPICs and RACs in the context of claims reviews of this nature, we cannot provide assurance as to the timing or outcomes of these disputes. As such, we make estimates for these claims based on our historical experience and success rates in the claims adjudication process, which is the same process we follow for appealing denials of certain diagnosis codes by MACs. As the ultimate results of these audits impact our estimates of amounts determined to be due to Encompass Health under these reimbursement programs, our reserve for claims that are part of this post-payment claims review process are recorded to </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Net operating revenues</font><font style="font-family:inherit;font-size:10pt;">. During </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, our adjustment to </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Net operating revenues </font><font style="font-family:inherit;font-size:10pt;">for claims that are part of this post-payment claims review process was not material. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our performance obligations relate to contracts with a duration of less than one year. Therefore, we elected to apply the optional exemption to not disclose the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. These unsatisfied or partially unsatisfied performance obligations primarily relate to services provided at the end of the reporting period.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are subject to changes in government legislation that could impact Medicare payment levels and changes in payor patterns that may impact the level and timing of payments for services rendered.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Inpatient Rehabilitation Revenues</font></div><div style="line-height:120%;padding-bottom:13px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inpatient rehabilitation segment revenues are recognized over time as the services are provided to the patient. The performance obligation is the rendering of services to the patient during the term of their inpatient stay. Revenues are recognized (or measured) using the input method as therapy, nursing, and auxiliary services are provided based on our estimate of the respective transaction price. Revenues recognized by our inpatient rehabilitation segment are subject to a number of elements which impact both the overall amount of revenue realized as well as the timing of the collection of the related accounts receivable. Factors considered in determining the estimated transaction price include the patient’s total length of stay for in-house patients, each patient’s discharge destination, the proportion of patients with secondary insurance coverage and the level of reimbursement under that secondary coverage, and the amount of charges that will be disallowed by payors. Such additional factors are assumed to remain consistent with the experience for patients discharged in similar time periods for the same payor classes.</font></div><div style="line-height:120%;padding-bottom:13px;padding-top:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Home Health and Hospice Revenues</font></div><div style="line-height:120%;padding-bottom:13px;padding-top:4px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Home Health</font></div><div style="line-height:120%;padding-bottom:13px;padding-top:4px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the Medicare home health prospective payment system, we are paid by Medicare based on episodes of care. The performance obligation is the rendering of services to the patient during the term of the episode of care. An episode of care is defined as a length of stay up to 60 days, with multiple continuous episodes allowed. A base episode payment is established by the Medicare program through federal regulation. The base episode payment can be adjusted based on each patient’s health including clinical condition, functional abilities, and service needs, as well as for the applicable geographic wage index, low utilization, patient transfers, and other factors. The services covered by the episode payment include all disciplines of care in addition to medical supplies.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We bill a portion of reimbursement from each Medicare episode near the start of each episode, and the resulting cash payment is typically received before all services are rendered. As we provide home health services to our patients on a scheduled basis over the episode of care in a manner that approximates a pro rata pattern, revenue for the episode of care is recorded over an average length of treatment period using a calendar day prorating method. The amount of revenue recognized for episodes of care which are incomplete at period end is based on the pro rata number of days in the episode which have been completed as of the period end date. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the difference between the cash received from Medicare for a request for anticipated payment on episodes in progress and the associated estimated revenue </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">was not material</font><font style="font-family:inherit;font-size:10pt;"> and was recorded in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other current liabilities</font><font style="font-family:inherit;font-size:10pt;"> in our consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are subject to certain Medicare regulations affecting outlier revenue if our patient’s care was unusually costly. Regulations require a cap on all outlier revenue at 10% of total Medicare revenue received by each provider during a cost reporting year. Management has reviewed the potential cap. Adjustments to the transaction price for the outlier cap </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">were not material</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">as of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For episodic-based rates that are paid by other insurance carriers, including Medicare Advantage, we recognize revenue in a similar manner as discussed above for Medicare revenues. However, these rates can vary based upon the negotiated terms. For non-episodic-based revenue, revenue is recorded on an accrual basis based upon the date of service at amounts equal to our estimated per-visit transaction price. Price concessions, including contractual allowances for the differences between our standard rates and the applicable contracted rates, as well as estimated uncollectible amounts from patients, are recorded as decreases to the transaction price.</font></div><div style="line-height:120%;padding-bottom:13px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Hospice</font></div><div style="line-height:120%;padding-bottom:13px;padding-top:4px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medicare revenues for hospice are recognized and recorded on an accrual basis using the input method based on the number of days a patient has been on service at amounts equal to an estimated daily or hourly payment rate. The performance obligation is the rendering of services to the patient during each day that they are on hospice care. The payment rate is dependent on whether a patient is receiving routine home care, general inpatient care, continuous home care or respite care. Adjustments to Medicare revenues are recorded based on an inability to obtain appropriate billing documentation or authorizations acceptable to the payor or other reasons unrelated to credit risk. Hospice companies are subject to two specific payment limit caps under the Medicare program. One limit relates to inpatient care days that exceed 20% of the total days of hospice care provided for the year. The second limit relates to an aggregate Medicare reimbursement cap calculated by the MAC. Adjustments to the transaction price for these caps </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">were not material</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For non-Medicare hospice revenues, we record gross revenue on an accrual basis based upon the date of service at amounts equal to our estimated per day transaction price. Price concessions, including contractual adjustments for the difference between our standard rates and the amounts estimated to be realizable from patients and third parties for services provided, are recorded as decreases to the transaction price and thus reduce our </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Net operating revenues</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>

CY2018

us-gaap

Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense

ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the changes in our self-insurance reserves for the years ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> (in millions):</font></div><div style="line-height:120%;padding-bottom:13px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:95.5078125%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:54%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at beginning of period, gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">171.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">171.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">142.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Reinsurance receivables</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(39.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(41.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at beginning of period, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">131.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increase for the provision of current year claims</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decrease for the provision of prior year claims</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expenses related to discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payments related to current year claims</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payments related to prior year claims</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(27.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at end of period, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">131.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Add: Reinsurance receivables</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at end of period, gross</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">160.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">171.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">171.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

CY2018

us-gaap

Use Of Estimates

UseOfEstimates

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates and Assumptions—</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of our consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Significant estimates and assumptions are used for, but not limited to: (1) revenue reserves for contractual adjustments and uncollectible amounts; (2) fair value of acquired assets and assumed liabilities in business combinations; (3) asset impairments, including goodwill; (4) depreciable lives of assets; (5) useful lives of intangible assets; (6) economic lives and fair value of leased assets; (7) income tax valuation allowances; (8) uncertain tax positions; (9) fair value of stock options and restricted stock containing a market condition; (10) fair value of redeemable noncontrolling interests; (11) reserves for self-insured healthcare plans; (12) reserves for professional, workers’ compensation, and comprehensive general insurance liability risks; and (13) contingency and litigation reserves. Future events and their effects cannot be predicted with certainty; accordingly, our accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of our consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as our operating environment changes. We evaluate and update our assumptions and estimates on an ongoing basis and may employ outside experts to assist in our evaluation, as considered necessary. Actual results could differ from those estimates.</font></div></div>

Name	View Source	Status
0000785161-19-000011-index-headers.html	Edgar Link	pending
0000785161-19-000011-index.html	Edgar Link	pending
0000785161-19-000011.txt	Edgar Link	pending
0000785161-19-000011-xbrl.zip	Edgar Link	pending
chart-6f8c0a7e0ec45246b3e.jpg	Edgar Link	pending
ehc-20181231.xml	Edgar Link	completed
ehc-20181231.xsd	Edgar Link	pending
ehc-20181231_cal.xml	Edgar Link	unprocessable
ehc-20181231_def.xml	Edgar Link	unprocessable
ehc-20181231_lab.xml	Edgar Link	unprocessable
ehc-20181231_pre.xml	Edgar Link	unprocessable
ehc10k123118.htm	Edgar Link	pending
ehc10k123118ex211.htm	Edgar Link	pending
ehc10k123118ex231.htm	Edgar Link	pending
ehc10k123118ex311.htm	Edgar Link	pending
ehc10k123118ex312.htm	Edgar Link	pending
ehc10k123118ex321.htm	Edgar Link	pending
ehc10k123118ex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EHC
Encompass Health Corp Stock $ehc

2017 Q4 Form 10-K Financial Statement

#000078516119000011 Filed on February 27, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EHC Encompass Health Corp Stock $ehc

2017 Q4 Form 10-K Financial Statement

#000078516119000011 Filed on February 27, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EHC
Encompass Health Corp Stock $ehc